A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.
Substances that are destructive to protozoans.
A genus of flagellate protozoa comprising several species that are pathogenic for humans. Organisms of this genus have an amastigote and a promastigote stage in their life cycles. As a result of enzymatic studies this single genus has been divided into two subgenera: Leishmania leishmania and Leishmania viannia. Species within the Leishmania leishmania subgenus include: L. aethiopica, L. arabica, L. donovani, L. enrietti, L. gerbilli, L. hertigi, L. infantum, L. major, L. mexicana, and L. tropica. The following species are those that compose the Leishmania viannia subgenus: L. braziliensis, L. guyanensis, L. lainsoni, L. naiffi, and L. shawi.
A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). Human infections are confined almost entirely to children. This parasite is commonly seen in dogs, other Canidae, and porcupines with humans considered only an accidental host. Transmission is by Phlebotomus sandflies.
A parasitic hemoflagellate of the subgenus Leishmania viannia that infects man and animals. It causes cutaneous (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), and mucocutaneous leishmaniasis (LEISHMANIASIS, MUCOCUTANEOUS) depending on the subspecies of this organism. The sandfly, Lutzomyia, is the vector. The Leishmania braziliensis complex includes the subspecies braziliensis and peruviana. Uta, a form of cutaneous leishmaniasis in the New World, is caused by the subspecies peruviana.
A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). The sandfly genera Phlebotomus and Lutzomyia are the vectors.
Small, hairy, moth-like flies which are of considerable public health importance as vectors of certain pathogenic organisms. Important disease-related genera are PHLEBOTOMUS, Lutzomyia, and Sergentomyia.
A form of LEISHMANIASIS, CUTANEOUS caused by Leishmania aethiopica in Ethiopia and Kenya, L. pifanoi in Venezuela, L. braziliensis in South America, and L. mexicana in Central America. This disease is characterized by massive dissemination of skin lesions without visceral involvement.
1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium.
Vaccines or candidate vaccines used to prevent infection with LEISHMANIA.
A metallic element that has the atomic symbol Sb, atomic number 51, and atomic weight 121.75. It is used as a metal alloy and as medicinal and poisonous salts. It is toxic and an irritant to the skin and the mucous membranes.
A genus of PSYCHODIDAE which functions as the vector of a number of pathogenic organisms, including LEISHMANIA DONOVANI; LEISHMANIA TROPICA; Bartonella bacilliformis, and the Pappataci fever virus (SANDFLY FEVER NAPLES VIRUS).
Antimony complex where the metal may exist in either the pentavalent or trivalent states. The pentavalent gluconate is used in leishmaniasis. The trivalent gluconate is most frequently used in schistosomiasis.
A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and rodents. This taxonomic complex includes species which cause a disease called Oriental sore which is a form of cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) of the Old World.
Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used.
A parasitic hemoflagellate of the subgenus Leishmania viannia that infects man and animals and causes mucocutaneous leishmaniasis (LEISHMANIASIS, MUCOCUTANEOUS). Transmission is by Lutzomyia sandflies.
A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) of the Old World. Transmission is by Phlebotomus sandflies.
A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals including rodents. The Leishmania mexicana complex causes both cutaneous (LEISHMANIASIS, CUTANEOUS) and diffuse cutaneous leishmaniasis (LEISHMANIASIS, DIFFUSE CUTANEOUS) and includes the subspecies amazonensis, garnhami, mexicana, pifanoi, and venezuelensis. L. m. mexicana causes chiclero ulcer, a form of cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) in the New World. The sandfly, Lutzomyia, appears to be the vector.
Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered.
Immunoglobulins produced in a response to PROTOZOAN ANTIGENS.
Insects that transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.
The constant presence of diseases or infectious agents within a given geographic area or population group. It may also refer to the usual prevalence of a given disease with such area or group. It includes holoendemic and hyperendemic diseases. A holoendemic disease is one for which a high prevalent level of infection begins early in life and affects most of the child population, leading to a state of equilibrium such that the adult population shows evidence of the disease much less commonly than do children (malaria in many communities is a holoendemic disease). A hyperendemic disease is one that is constantly present at a high incidence and/or prevalence rate and affects all groups equally. (Last, A Dictionary of Epidemiology, 3d ed, p53, 78, 80)
Deoxyribonucleic acid that makes up the genetic material of protozoa.
A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed)
I'm sorry for any confusion, but "Brazil" is not a medical term or concept, it is a country located in South America, known officially as the Federative Republic of Brazil. If you have any questions related to health, medicine, or science, I'd be happy to help answer those!
An oligosaccharide antibiotic produced by various STREPTOMYCES.
Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
DNA of kinetoplasts which are specialized MITOCHONDRIA of trypanosomes and related parasitic protozoa within the order KINETOPLASTIDA. Kinetoplast DNA consists of a complex network of numerous catenated rings of two classes; the first being a large number of small DNA duplex rings, called minicircles, approximately 2000 base pairs in length, and the second being several dozen much larger rings, called maxicircles, approximately 37 kb in length.
Suspensions of attenuated or killed protozoa administered for the prevention or treatment of infectious protozoan disease.
Measure of the number of the PARASITES present in a host organism.
The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
A country in northeastern Africa. The capital is Khartoum.
Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.
Animate or inanimate sources which normally harbor disease-causing organisms and thus serve as potential sources of disease outbreaks. Reservoirs are distinguished from vectors (DISEASE VECTORS) and carriers, which are agents of disease transmission rather than continuing sources of potential disease outbreaks.
The reduction or regulation of the population of noxious, destructive, or dangerous insects through chemical, biological, or other means.
I'm sorry for any confusion, but "Venezuela" is a country in South America and not a medical term or concept. Therefore, it doesn't have a medical definition.
The study of parasites and PARASITIC DISEASES.
Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
I'm sorry for any confusion, but "India" is not a medical term that can be defined in a medical context. It is a geographical location, referring to the Republic of India, a country in South Asia. If you have any questions related to medical topics or definitions, I would be happy to help with those!
Inbred BALB/c mice are a strain of laboratory mice that have been selectively bred to be genetically identical to each other, making them useful for scientific research and experiments due to their consistent genetic background and predictable responses to various stimuli or treatments.
Proteins found in any species of protozoan.
I'm sorry for any confusion, but "Colombia" is not a medical term that can be defined in a medical context; rather, it's a country located in South America. If you have any questions related to medical terminology or health-related topics, I would be happy to help with those instead!
I'm sorry for any confusion, but the term "Argentina" is not a medical concept or condition that has a defined meaning within the medical field. Argentina is actually the second largest country in South America, and is known for its rich cultural history, diverse landscapes, and significant contributions to fields such as science, arts, and sports. If you have any questions related to healthcare, medicine, or biology, I would be happy to try to help answer those!
A skin ulcer is a breakdown of the skin's surface and underlying tissues, often caused by prolonged pressure, infection, or poor circulation, leading to a loss of continuity in the epidermis and dermis, potentially extending into deeper layers such as subcutaneous tissue, muscle, and bone.
Invertebrates or non-human vertebrates which transmit infective organisms from one host to another.
Diagnostic procedures involving immunoglobulin reactions.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity.
I'm sorry for any confusion, but "Nepal" is not a medical term that has a definition in the field of medicine. It is actually the name of a country located in South Asia, known officially as the Federal Democratic Republic of Nepal. If you have any questions related to medicine or health, I would be happy to try and help answer those for you!
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
Diseases of non-human animals that may be transmitted to HUMANS or may be transmitted from humans to non-human animals.
Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed)
I'm sorry for any confusion, but "Bolivia" is not a medical term that has a definition in the field of medicine. It is actually the name of a country, specifically the Plurinational State of Bolivia, located in South America. If you have any questions related to medicine or health, I would be happy to try and help answer those for you!
I'm sorry for any confusion, but "Peru" is not a medical term or concept, it is a country located in South America, known officially as the Republic of Peru. If you have any questions about medical topics that I can help clarify, please let me know!
The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES.
Bactericidal cationic quaternary ammonium surfactant used as a topical anti-infective agent. It is an ingredient in medicaments, deodorants, mouthwashes, etc., and is used to disinfect apparatus, etc., in the food processing and pharmaceutical industries, in surgery, and also as a preservative. The compound is toxic orally as a result of neuromuscular blockade.
An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
Number of individuals in a population relative to space.
Infections with the protozoa of the phylum EUGLENOZOA.
Tests that demonstrate the relative effectiveness of chemotherapeutic agents against specific parasites.
Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA.
Diseases that are underfunded and have low name recognition but are major burdens in less developed countries. The World Health Organization has designated six tropical infectious diseases as being neglected in industrialized countries that are endemic in many developing countries (HELMINTHIASIS; LEPROSY; LYMPHATIC FILARIASIS; ONCHOCERCIASIS; SCHISTOSOMIASIS; and TRACHOMA).
"Panama" is not a recognized medical term or condition in healthcare and medicine. It might be a reference to a location, but it does not have a specific medical meaning in itself.
The area of medicine concerned with the effects on health and disease due to geographic factors such as CLIMATE, environmental conditions, and geographic location.
A type of affinity chromatography where ANTIBODIES are used in the affinity capture reaction on the solid support, in the mobile phase, or both.
Any of certain small mammals of the order Hyracoidea.
I'm sorry for any confusion, but "Afghanistan" is not a medical term and does not have a medical definition. It is a country located in South-Central Asia. If you have any questions related to medical terminology or health concerns, I would be happy to help answer those!
A genus of the family Muridae having three species. The present domesticated strains were developed from individuals brought from Syria. They are widely used in biomedical research.
A country in northern Africa between ALGERIA and LIBYA. Its capital is Tunis.
A mammalian order which consists of 29 families and many genera.
A cytokine produced by a variety of cell types, including T-LYMPHOCYTES; MONOCYTES; DENDRITIC CELLS; and EPITHELIAL CELLS that exerts a variety of effects on immunoregulation and INFLAMMATION. Interleukin-10 combines with itself to form a homodimeric molecule that is the biologically active form of the protein.
Divisions of the year according to some regularly recurrent phenomena usually astronomical or climatic. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
Skin tests in which the sensitizer is injected.
An independent state in eastern Africa. Ethiopia is located in the Horn of Africa and is bordered on the north and northeast by Eritrea, on the east by Djibouti and Somalia, on the south by Kenya, and on the west and southwest by Sudan. Its capital is Addis Ababa.
I am not aware of any established medical definition for "Iran" as it is primarily used to refer to a country located in the Middle East, known officially as the Islamic Republic of Iran. If you are looking for information on healthcare or medical conditions within Iran, I would be happy to help with that!
A form of fluorescent antibody technique commonly used to detect serum antibodies and immune complexes in tissues and microorganisms in specimens from patients with infectious diseases. The technique involves formation of an antigen-antibody complex which is labeled with fluorescein-conjugated anti-immunoglobulin antibody. (From Bennington, Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)
The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.)
Areas designated for use by the armed forces personnel.
I'm sorry for any confusion, but "Ecuador" is a country in South America and not a medical term. The term you might be looking for is "ecdysone," which is a hormone found in arthropods that controls their molting process.
An encapsulated lymphatic organ through which venous blood filters.
A republic in the north of South America, bordered on the west by GUYANA (British Guiana) and on the east by FRENCH GUIANA. Its capital is Paramaribo. It was formerly called Netherlands Guiana or Dutch Guiana or Surinam. Suriname was first settled by the English in 1651 but was ceded to the Dutch by treaty in 1667. It became an autonomous territory under the Dutch crown in 1954 and gained independence in 1975. The country was named for the Surinam River but the meaning of that name is uncertain. (From Webster's New Geographical Dictionary, 1988, p1167 & Room, Brewer's Dictionary of Names, 1992, p526)
Subset of helper-inducer T-lymphocytes which synthesize and secrete interleukin-2, gamma-interferon, and interleukin-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions.
Infections that do not exhibit symptoms.
Bites and stings inflicted by insects.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
I'm sorry for any confusion, but "Bangladesh" is a country located in South Asia, not a medical term or concept. Therefore, it doesn't have a medical definition. It shares borders with India, Myanmar (Burma), and Bay of Bengal. The population is primarily Bengali, and the official language is Bangla (Bengali). The capital city is Dhaka. If you have any questions related to medicine or health, feel free to ask!
The systematic surveying, mapping, charting, and description of specific geographical sites, with reference to the physical features that were presumed to influence health and disease. Medical topography should be differentiated from EPIDEMIOLOGY in that the former emphasizes geography whereas the latter emphasizes disease outbreaks.
Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
Eyelid diseases refer to various medical conditions that affect the function, structure, or appearance of the eyelids, including inflammatory, infectious, neoplastic, congenital, and traumatic disorders, which can impact vision, comfort, and overall ocular health.
Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.
USSR (Union of Soviet Socialist Republics) cannot be provided as a medical definition, as it is not a medical term; it refers to a former political state that existed from 1922 until 1991 and was dissolved into multiple independent countries.
Quinolines substituted in any position by one or more amino groups.
The MEDITERRANEAN SEA, the MEDITERRANEAN ISLANDS, and the countries bordering on the sea collectively.
A French overseas department on the northeast coast of South America. Its capital is Cayenne. It was first settled by the French in 1604. Early development was hindered because of the presence of a penal colony. The name of the country and the capital are variants of Guyana, possibly from the native Indian Guarani guai (born) + ana (kin), implying a united and interrelated race of people. (From Webster's New Geographical Dictionary, 1988, p418 & Room, Brewer's Dictionary of Names, 1992, p195)
Infection with protozoa of the genus TRYPANOSOMA.
A manifestation of severe ROSACEA resulting in significant enlargement of the NOSE and occurring primarily in men. It is caused by hypertrophy of the SEBACEOUS GLANDS and surrounding CONNECTIVE TISSUE. The nose is reddened and marked with TELANGIECTASIS.
A soluble factor produced by activated T-LYMPHOCYTES that induces the expression of MHC CLASS II GENES and FC RECEPTORS on B-LYMPHOCYTES and causes their proliferation and differentiation. It also acts on T-lymphocytes, MAST CELLS, and several other hematopoietic lineage cells.
The relationship between an invertebrate and another organism (the host), one of which lives at the expense of the other. Traditionally excluded from definition of parasites are pathogenic BACTERIA; FUNGI; VIRUSES; and PLANTS; though they may live parasitically.
A country located in north Africa, bordering the Atlantic Ocean and the Mediterranean Sea, with a southern border with Western Sahara, eastern border with Algeria. The capital is Rabat.
The branch of medicine concerned with diseases, mainly of parasitic origin, common in tropical and subtropical regions.
Facial dermatoses refers to various skin conditions that affect the face, causing symptoms such as redness, inflammation, papules, pustules, scaling, or pigmentation changes, which can be caused by a range of factors including genetics, infections, allergies, and environmental factors.
Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics.
An increased reactivity to specific antigens mediated not by antibodies but by cells.
Aspects of health and disease related to travel.
Infections or infestations with parasitic organisms. They are often contracted through contact with an intermediate vector, but may occur as the result of direct exposure.
Simultaneous infection of a host organism by two or more pathogens. In virology, coinfection commonly refers to simultaneous infection of a single cell by two or more different viruses.
A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS.
Infectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode.
The active insecticidal constituent of CHRYSANTHEMUM CINERARIIFOLIUM flowers. Pyrethrin I is the pyretholone ester of chrysanthemummonocarboxylic acid and pyrethrin II is the pyretholone ester of chrysanthemumdicarboxylic acid monomethyl ester.
Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.
Persons including soldiers involved with the armed forces.
Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
The geographical area of Asia comprising KAZAKHSTAN; KYRGYZSTAN; TAJIKISTAN; TURKMENISTAN; and UZBEKISTAN. The desert region of Kara Kum (Qara Qum) is largely in Turkmenistan and the desert region of Kyzyl Kum (Kizil Kum or Qizil Qum), is in Uzbekistan and Kazakhstan. (From Webster's New Geographical Dictionary, 1988, p233, 590, 636)
The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.
A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.
A heterodimeric cytokine that plays a role in innate and adaptive immune responses. Interleukin-12 is a 70 kDa protein that is composed of covalently linked 40 kDa and 35 kDa subunits. It is produced by DENDRITIC CELLS; MACROPHAGES and a variety of other immune cells and plays a role in the stimulation of INTERFERON-GAMMA production by T-LYMPHOCYTES and NATURAL KILLER CELLS.
The continuous sequence of changes undergone by living organisms during the post-embryonic developmental process, such as metamorphosis in insects and amphibians. This includes the developmental stages of apicomplexans such as the malarial parasite, PLASMODIUM FALCIPARUM.
A chronic communicable infection which is a principal or polar form of LEPROSY. This disorder is caused by MYCOBACTERIUM LEPRAE and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage.
Clinical manifestation of excessive LEANNESS usually caused by disease or a lack of nutrition (MALNUTRITION).
The intergenic DNA segments that are between the ribosomal RNA genes (internal transcribed spacers) and between the tandemly repeated units of rDNA (external transcribed spacers and nontranscribed spacers).
The outer part of the hearing system of the body. It includes the shell-like EAR AURICLE which collects sound, and the EXTERNAL EAR CANAL, the TYMPANIC MEMBRANE, and the EXTERNAL EAR CARTILAGES.
A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.
The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors.
The medical science concerned with the prevention, diagnosis, and treatment of diseases in animals.
Skin diseases caused by ARTHROPODS; HELMINTHS; or other parasites.
Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins.
The geographical area of Africa comprising BURUNDI; DJIBOUTI; ETHIOPIA; KENYA; RWANDA; SOMALIA; SUDAN; TANZANIA; and UGANDA.
The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.
The inhabitants of rural areas or of small towns classified as rural.
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system.
Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role.
An order of ungulates having an odd number of toes, including the horse, tapir, and rhinoceros. (Dorland, 27th ed)
Liver diseases caused by infections with PARASITES, such as tapeworms (CESTODA) and flukes (TREMATODA).
I'm sorry for any confusion, but "Sri Lanka" is not a medical term that can be defined in a medical context; it is the name of a country located in South Asia, known for its diverse landscapes and rich biodiversity.
EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
The longterm manifestations of WEATHER. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases.
PHENOTHIAZINES with an amino group at the 3-position that are green crystals or powder. They are used as biological stains.
A genus of RNA protozoan viruses of the family TOTIVIRIDAE. Several different strains of Leishmania are infected by a variety of viral species. The type species is Leishmania RNA virus 1-1.
The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species.
A microtubule-disrupting pre-emergence herbicide.
Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules.
The inhabitants of a city or town, including metropolitan areas and suburban areas.
Proteins and peptides found in SALIVA and the SALIVARY GLANDS. Some salivary proteins such as ALPHA-AMYLASES are enzymes, but their composition varies in different individuals.
Narrow pieces of material impregnated or covered with a substance used to produce a chemical reaction. The strips are used in detecting, measuring, producing, etc., other substances. (From Dorland, 28th ed)
Computer systems capable of assembling, storing, manipulating, and displaying geographically referenced information, i.e. data identified according to their locations.
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
Therapy with two or more separate preparations given for a combined effect.
A schistosomicide possibly useful against other parasites. It has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects.
The science dealing with the earth and its life, especially the description of land, sea, and air and the distribution of plant and animal life, including humanity and human industries with reference to the mutual relations of these elements. (From Webster, 3d ed)
The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.
Proteins prepared by recombinant DNA technology.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
A ureahydrolase that catalyzes the hydrolysis of arginine or canavanine to yield L-ornithine (ORNITHINE) and urea. Deficiency of this enzyme causes HYPERARGININEMIA. EC 3.5.3.1.
Drugs used to treat or prevent parasitic infections.
Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS.
Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment.
A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.

U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. (1/1657)

In August 1997, AmBisome (liposomal amphotericin B, Nexstar, San Dimas, CA) was the first drug approved for the treatment of visceral leishmaniasis by the U.S. Food and Drug Administration. The growing recognition of emerging and reemerging infections warrants that safe and effective agents to treat such infections be readily available in the United States. The following discussion of the data submitted in support of the New Drug Application for AmBisome for the treatment of visceral leishmaniasis shows the breadth of data from clinical trials that can be appropriate to support approval for drugs to treat tropical diseases.  (+info)

Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients. (2/1657)

Visceral leishmaniasis, or kala-azar, a fatal tropical disease, remains problematic, as early diagnosis is difficult and treatment often results in drug resistance and relapse. We have developed a sensitive enzyme-linked immunosorbent assay (ELISA), using leishmanial membrane antigenic extracts (LAg) to detect specific antibody responses in 25 untreated Indian visceral leishmaniasis patients. To investigate the pathogenetic significance of isotype markers in kala-azar, relative levels of specific immunoglobulin G (IgG), IgM, IgA, IgE, and IgG subclasses were analyzed under clinically established diseased conditions. Since LAg showed higher sensitivity for specific IgG than lysate, the immunoglobulin isotype responses were evaluated, with LAg as antigen. Compared to 60 controls, which included patients with malaria, tuberculosis, leprosy, and typhoid and healthy subjects, visceral leishmaniasis patients showed significantly higher IgG (100% sensitivity, 85% specificity), IgM (48% sensitivity, 100% specificity), and IgE (44% sensitivity, 98.3% specificity) responses. Low levels of IgA in visceral leishmaniasis patients contrasted with a 13-fold-higher reactivity in sera from patients with leprosy. Among IgG subclasses, IgG1, -3, and -4 responses were significantly higher in visceral leishmaniasis patients than in the controls. IgG2 response, however, was significantly higher (twofold) in leprosy than even visceral leishmaniasis patients. The rank orders for sensitivity (IgG = IgG1 = IgG3 = IgG4 > IgG2 > IgM > IgE > IgA) and specificity (IgM = IgG3 > IgE > IgG4 > IgG2 > IgG > IgG1 > IgA) for LAg-specific antibody responses suggest the potentiality of IgG3 as a diagnostic marker for visceral leishmaniasis.  (+info)

Value of Western blotting in the clinical follow-up of canine leishmaniasis. (3/1657)

Specific serum antibody levels in Leishmania infantum-infected dogs treated with a combination of glucantime and allopurinol were estimated by indirect immunofluorescence and Western blotting. The sensitivity of Western blot was greater than that obtained with immunofluorescence titration. In general, both diagnostic methods concurred with the post-treatment clinical status of the animals. Clinical improvement of successfully treated dogs was related to lower immunofluorescence titers and simpler and/or less reactive immunodetection patterns in Western blotting. The recognition, by infected dogs, of certain low molecular weight antigens, particularly one of approximately 26 kDa, was restricted to pretreatment samples and a single animal in relapse thus apparently constituting an active infection marker.  (+info)

Multi-centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis. (4/1657)

OBJECTIVE: To evaluate the repeatability and reproducibility of the serological direct agglutination test (DAT) for visceral leishmaniasis (VL) with aqueous antigen in a multi-centre study in VL-endemic areas in Sudan, Kenya and Nepal. METHODS: Repeatability within each centre and reproducibility between the centres' results and an external reference laboratory (Belgium) was assessed on 1596 triplicate plain blood samples collected on filter paper. RESULTS: High kappa values (range 0.86-0.97) indicated excellent DAT repeatability within the centres. The means of the titre differences between the reference laboratory and the centres in Sudan, Kenya and Nepal (2.3, 2.4 and 1.1, respectively, all significantly different from 0) showed weak reproducibility across centres. 95% of the titre differences between the reference laboratory and the respective centres were accounted for by large intervals: 0.6-9 fold titre variation for Sudan, 0.7-8 fold for Kenya and 0.26-4 fold for Nepal. CONCLUSION: High repeatability of DAT confirms its potential, but reproducibility problems remain an obstacle to its routine use in the field. Reproducibility was hindered by alteration of the antigen through temperature and shaking, especially in Kenya and Sudan, and by nonstandardization of the test reading. DAT handling procedures and antigen quality must be carefully standardized and monitored when introducing this test into routine practice.  (+info)

Towards a kala azar risk map for Sudan: mapping the potential distribution of Phlebotomus orientalis using digital data of environmental variables. (5/1657)

The need to define the geographical distribution of Phlebotomus orientalis results from its importance as the dominant vector of kala azar (visceral Iceishmaniasis) in Sudan. Recent epidermics of this disease in southern and eastern Sudan caused an estimated 100000 deaths and have renewed the impetus for defining the ecological boundaries of the vector. This information is an essential prerequisite to the production of a risk map for kala azar. This study uses data on the presence and absence of P. orientalis from 44 collecting sites across the central belt of Sudan. A logistic regression model was used to estimate the probability of the presence of P. orientalis at each collecting site as a function of climatic and environmental variables (rainfall; temperature; altitude; soil type and the satellite-derived environmental proxies - Normalized Difference Vegetation Index and Land Surface Temperature). The logistic regression model indicates mean annual maximum daily temperature and soil type as the most important ecological determinants of P. orientalis distribution. An initial risk map was created in a raster-based geographical information system which delineates the area where P. orientalis may occur. This map was then refined using a mask layer indicating the known rainfall-based boundaries of the distribution of Acacia-Balanites woodland - a woodland type known to be associated with the distribution of this vector. The predictive performance of the risk map is discussed.  (+info)

Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis. (6/1657)

A wide variety of biologically active compounds contain indole and quinoline nuclei. Some novel indolylquinoline derivatives were synthesized from indole by Friedel-Crafts acylation reaction. Out of the four derivatives tested, 2-(2''-acetamidobenzyl)-3-(3'-indolylquinoline) (C) had no effect on the promastigotes or amastigotes of Leishmania donovani in vitro. The remaining three analogues, 2-(2''-dichloroacetamidobenzyl)-3-(3'-indolylquinoline) (A), 2-(2''-chloroacetamidobenzyl)-3-(3'-indolylquinoline) (B), and 2-(2''-aminobenzyl)-3-(3'-indolylquinoline) (D), inhibited the growth of L. donovani promastigotes in vitro and were cytotoxic to both the promastigote and amastigote forms of the parasite. These three derivatives were also effective in eliminating L. donovani amastigotes from BALB/c mouse peritoneal macrophages in vitro. One indolylquinoline derivative [A] was used to treat established visceral leishmaniasis in BALB/c mice. This compound was significantly more effective than sodium antimony gluconate (SAG) in reducing the splenic parasite load at a much lower concentration (5% of SAG). Our results suggest that indolylquinoline derivatives may be exploited as antileishmanial agents.  (+info)

Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. (7/1657)

Visceral leishmaniosis (VL) due to Leishmania infantum (L. chagasi) is a lethal disease if untreated, but asymptomatic L. infantum infections have been reported previously. A better understanding of parasite transmission, dissemination, and survival in the human host is needed. The purpose of this study was to assess whether L. infantum circulated in peripheral blood of subjects with no history of VL. Sera from 565 blood donors were screened by Western blotting to detect Leishmania-specific antibodies and identify individuals with probable past exposure to Leishmania. Seropositivity was found in 76 donors whose buffy coats were examined by PCR and direct culture. The parasite minicircle kinetoplast DNA was amplified from blood samples of nine donors. Promastigotes were detected by culture in blood samples from nine donors. Only two donors were PCR and culture positive. These results indicate that L. infantum circulates intermittently and at low density in the blood of healthy seropositive individuals, who thus appear to be asymptomatic carriers. Implications for the safety of blood transfusion are discussed.  (+info)

Cost-effectiveness analysis of humanitarian relief interventions: visceral leishmaniasis treatment in the Sudan. (8/1657)

Spending by aid agencies on emergencies has quadrupled over the last decade, to over US$6 billion. To date, cost-effectiveness has seldom been considered in the prioritization and evaluation of emergency interventions. The sheer volume of resources spent on humanitarian aid and the chronicity of many humanitarian interventions call for more attention to be paid to the issue of 'value for money'. In this paper we present data from a major humanitarian crisis, an epidemic of visceral leishmaniasis (VL) in war-torn Sudan. The special circumstances provided us, in retrospect, with unusually accurate data on excess mortality, costs of the intervention and its effects, thus allowing us to express cost-effectiveness as the cost per Disability Adjusted Life Year (DALY) averted. The cost-effectiveness ratio, of US$18.40 per DALY (uncertainty range between US$13.53 and US$27.63), places the treatment of VL in Sudan among health interventions considered 'very good value for money' (interventions of less than US$25 per DALY). We discuss the usefulness of this analysis to the internal management of the VL programme, the procurement of funds for the programme, and more generally, to priority setting in humanitarian relief interventions. We feel that in evaluations of emergency interventions attempts could be made more often to perform cost-effectiveness analyses, including the use of DALYs, provided that the outcomes of these analyses are seen in the broad context of the emergency situation and its consequences on the affected population. This paper provides a first contribution to what is hoped to become an international database of cost-effectiveness studies of health interventions during relief operations, which use a comparable measure of health outcome such as the DALY.  (+info)

Visceral leishmaniasis (VL), also known as kala-azar, is a systemic protozoan disease caused by the Leishmania donovani complex. It is the most severe form of leishmaniasis and is characterized by fever, weight loss, anemia, hepatosplenomegaly, and pancytopenia. If left untreated, it can be fatal in over 95% of cases within 2 years of onset of symptoms. It is transmitted to humans through the bite of infected female sandflies (Phlebotomus spp. or Lutzomyia spp.). The parasites enter the skin and are taken up by macrophages, where they transform into amastigotes and spread to internal organs such as the spleen, liver, and bone marrow. Diagnosis is typically made through demonstration of the parasite in tissue samples or through serological tests. Treatment options include antimonial drugs, amphotericin B, miltefosine, and paromomycin. Prevention measures include vector control, early detection and treatment, and protection against sandfly bites.

Cutaneous leishmaniasis is a neglected tropical disease caused by infection with Leishmania parasites, which are transmitted through the bite of infected female sandflies. The disease primarily affects the skin and mucous membranes, causing lesions that can be disfiguring and stigmatizing. There are several clinical forms of cutaneous leishmaniasis, including localized, disseminated, and mucocutaneous.

Localized cutaneous leishmaniasis is the most common form of the disease, characterized by the development of one or more nodular or ulcerative lesions at the site of the sandfly bite, typically appearing within a few weeks to several months after exposure. The lesions may vary in size and appearance, ranging from small papules to large plaques or ulcers, and can be painful or pruritic (itchy).

Disseminated cutaneous leishmaniasis is a more severe form of the disease, characterized by the widespread dissemination of lesions across the body. This form of the disease typically affects people with weakened immune systems, such as those with HIV/AIDS or those receiving immunosuppressive therapy.

Mucocutaneous leishmaniasis is a rare but severe form of the disease, characterized by the spread of infection from the skin to the mucous membranes of the nose, mouth, and throat. This can result in extensive tissue destruction, disfigurement, and functional impairment.

Cutaneous leishmaniasis is diagnosed through a combination of clinical evaluation, epidemiological data, and laboratory tests such as parasite detection using microscopy or molecular techniques, or serological tests to detect antibodies against the Leishmania parasites. Treatment options for cutaneous leishmaniasis include systemic or topical medications, such as antimonial drugs, miltefosine, or pentamidine, as well as physical treatments such as cryotherapy or thermotherapy. The choice of treatment depends on various factors, including the species of Leishmania involved, the clinical form of the disease, and the patient's overall health status.

Leishmaniasis is a complex of diseases caused by the protozoan parasites of the Leishmania species, which are transmitted to humans through the bite of infected female phlebotomine sandflies. The disease presents with a variety of clinical manifestations, depending upon the Leishmania species involved and the host's immune response.

There are three main forms of leishmaniasis: cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis (VL), also known as kala-azar. CL typically presents with skin ulcers, while MCL is characterized by the destruction of mucous membranes in the nose, mouth, and throat. VL, the most severe form, affects internal organs such as the spleen, liver, and bone marrow, causing symptoms like fever, weight loss, anemia, and enlarged liver and spleen.

Leishmaniasis is prevalent in many tropical and subtropical regions, including parts of Asia, Africa, South America, and southern Europe. The prevention strategies include using insect repellents, wearing protective clothing, and improving housing conditions to minimize exposure to sandflies. Effective treatment options are available for leishmaniasis, depending on the form and severity of the disease, geographical location, and the Leishmania species involved.

Mucocutaneous Leishmaniasis (MCL) is a chronic, granulomatous disease caused by an infection with Leishmania species, primarily L. braziliensis and L. guyanensis. It affects both the mucous membranes (such as those of the nose, mouth, and throat) and the skin.

The initial infection often occurs through the bite of an infected female sandfly, which transmits the parasitic protozoa into the host's skin. After a variable incubation period, the disease can manifest in different clinical forms, including localized cutaneous leishmaniasis (CL), disseminated cutaneous leishmaniasis, and mucocutaneous leishmaniasis.

MCL is characterized by progressive destruction of the mucous membranes, leading to deformities and functional impairments. The infection typically starts as a cutaneous lesion at the site of the sandfly bite, which heals spontaneously within several months. However, in some cases, the parasites disseminate to the mucous membranes, causing severe inflammation, ulceration, and tissue necrosis.

Symptoms of MCL include:

1. Destruction of nasal septum, leading to a saddle-nose deformity
2. Perforation of the palate or septum
3. Hoarseness or loss of voice due to laryngeal involvement
4. Difficulty swallowing and speaking
5. Chronic rhinitis, sinusitis, or otitis media
6. Severe disfigurement and functional impairments in advanced cases

Diagnosis is usually made by identifying the parasites in tissue samples (such as biopsies) using microscopy, culture, or PCR-based methods. Treatment typically involves systemic antiparasitic drugs, such as pentavalent antimonials, amphotericin B, miltefosine, or combination therapies, along with surgical interventions to reconstruct damaged tissues in advanced cases.

Antiprotozoal agents are a type of medication used to treat protozoal infections, which are infections caused by microscopic single-celled organisms called protozoa. These agents work by either killing the protozoa or inhibiting their growth and reproduction. They can be administered through various routes, including oral, topical, and intravenous, depending on the type of infection and the severity of the illness.

Examples of antiprotozoal agents include:

* Metronidazole, tinidazole, and nitazoxanide for treating infections caused by Giardia lamblia and Entamoeba histolytica.
* Atovaquone, clindamycin, and pyrimethamine-sulfadoxine for treating malaria caused by Plasmodium falciparum or other Plasmodium species.
* Pentamidine and suramin for treating African trypanosomiasis (sleeping sickness) caused by Trypanosoma brucei gambiense or T. b. rhodesiense.
* Nitroimidazoles, such as benznidazole and nifurtimox, for treating Chagas disease caused by Trypanosoma cruzi.
* Sodium stibogluconate and paromomycin for treating leishmaniasis caused by Leishmania species.

Antiprotozoal agents can have side effects, ranging from mild to severe, depending on the drug and the individual patient's response. It is essential to follow the prescribing physician's instructions carefully when taking these medications and report any adverse reactions promptly.

Leishmania is a genus of protozoan parasites that are the causative agents of Leishmaniasis, a group of diseases with various clinical manifestations. These parasites are transmitted to humans through the bite of infected female phlebotomine sandflies. The disease has a wide geographic distribution, mainly in tropical and subtropical regions, including parts of Asia, Africa, South America, and Southern Europe.

The Leishmania species have a complex life cycle that involves two main stages: the promastigote stage, which is found in the sandfly vector, and the amastigote stage, which infects mammalian hosts, including humans. The clinical manifestations of Leishmaniasis depend on the specific Leishmania species and the host's immune response to the infection.

The three main forms of Leishmaniasis are:

1. Cutaneous Leishmaniasis (CL): This form is characterized by skin lesions, such as ulcers or nodules, that can take several months to heal and may leave scars. CL is caused by various Leishmania species, including L. major, L. tropica, and L. aethiopica.

2. Visceral Leishmaniasis (VL): Also known as kala-azar, VL affects internal organs such as the spleen, liver, and bone marrow. Symptoms include fever, weight loss, anemia, and enlarged liver and spleen. VL is caused by L. donovani, L. infantum, and L. chagasi species.

3. Mucocutaneous Leishmaniasis (MCL): This form affects the mucous membranes of the nose, mouth, and throat, causing destruction of tissues and severe disfigurement. MCL is caused by L. braziliensis and L. guyanensis species.

Prevention and control measures for Leishmaniasis include vector control, early diagnosis and treatment, and protection against sandfly bites through the use of insect repellents and bed nets.

"Leishmania infantum" is a species of protozoan parasite that causes a type of disease known as leishmaniasis. It is transmitted to humans through the bite of infected female sandflies, primarily of the genus Phlebotomus in the Old World and Lutzomyia in the New World.

The parasite has a complex life cycle, alternating between the sandfly vector and a mammalian host. In the sandfly, it exists as an extracellular flagellated promastigote, while in the mammalian host, it transforms into an intracellular non-flagellated amastigote that multiplies within macrophages.

"Leishmania infantum" is the primary causative agent of visceral leishmaniasis (VL) in the Mediterranean basin, parts of Africa, Asia, and Latin America. VL, also known as kala-azar, is a systemic infection that can affect multiple organs, including the spleen, liver, bone marrow, and lymph nodes. Symptoms include fever, weight loss, anemia, and enlargement of the spleen and liver. If left untreated, VL can be fatal.

In addition to VL, "Leishmania infantum" can also cause cutaneous and mucocutaneous forms of leishmaniasis, which are characterized by skin lesions and ulcers, respectively. These forms of the disease are typically less severe than VL but can still result in significant morbidity.

Prevention and control measures for "Leishmania infantum" infection include avoiding sandfly bites through the use of insect repellents, protective clothing, and bed nets, as well as reducing sandfly breeding sites through environmental management. Effective treatment options are available for leishmaniasis, including antimonial drugs, amphotericin B, and miltefosine, among others. However, access to treatment and drug resistance remain significant challenges in many endemic areas.

Leishmania braziliensis is a species of protozoan parasite that causes American cutaneous leishmaniasis, also known as "espundia." This disease is transmitted to humans through the bite of infected female sandflies, primarily from the genus Lutzomyia. The infection can lead to skin lesions, ulcers, and scarring, and in some cases, it can disseminate and affect other organs, causing a more severe form of the disease called mucocutaneous leishmaniasis.

The parasite's life cycle involves two main stages: the promastigote stage, which occurs in the sandfly vector, and the amastigote stage, which takes place inside the mammalian host's macrophages. The infection can be diagnosed through various methods, including microscopic examination of tissue samples, culture isolation, or molecular techniques such as PCR. Treatment typically involves antiparasitic drugs, such as pentavalent antimonials, amphotericin B, or miltefosine, depending on the severity and location of the infection.

'Leishmania donovani' is a species of protozoan parasite that causes a severe form of visceral leishmaniasis, also known as kala-azar. This disease primarily affects the spleen, liver, and bone marrow, leading to symptoms such as fever, weight loss, anemia, and enlargement of the spleen and liver. The parasite is transmitted to humans through the bite of infected female sandflies. It's worth noting that this organism can also affect dogs and other animals, causing a disease known as canine leishmaniasis.

Psychodidae is a family of small, delicate flies known as psychodids or moth flies. The term "psychodidae" itself is the taxonomic name for this group of insects, and it does not have a specific medical definition. However, some species within this family are known to be vectors of various diseases, such as Leishmaniasis, which is transmitted through the bites of infected sandflies (a type of psychodid).

Therefore, in a broader medical context, "psychodidae" may refer to the group of flies that includes potential disease-carrying species. It's important to note that not all psychodids are vectors of diseases, and many species are harmless to humans.

Diffuse Cutaneous Leishmaniasis (DCL) is a rare form of leishmaniasis, a parasitic disease caused by the Leishmania species. In DCL, the skin is diffusely affected, with widespread non-ulcerated papular and nodular lesions that can involve the mucous membranes, but not the mucosa itself. The lesions may be disfiguring and can affect any part of the body, including the face. Unlike other forms of cutaneous leishmaniasis, DCL does not heal spontaneously and often requires systemic treatment. The disease is transmitted through the bite of infected female sandflies and is prevalent in tropical and subtropical regions, such as parts of Africa, Asia, South America, and the Mediterranean.

Meglumine is not a medical condition but a medication. It is an anticholinergic drug that is used as a diagnostic aid in the form of meglumine iodide, which is used to test for kidney function and to visualize the urinary tract. Meglumine is an amino sugar that is used as a counterion to combine with iodine to make meglumine iodide. It works by increasing the excretion of iodine through the kidneys, which helps to enhance the visibility of the urinary tract during imaging studies.

Leishmaniasis vaccines do not currently exist for human use, despite extensive research efforts. However, the concept and goal of a leishmaniasis vaccine refer to a potential prophylactic treatment that would prevent or significantly reduce the risk of contracting Leishmania infections, which cause various clinical manifestations of the disease.

Leishmaniasis is a vector-borne neglected tropical disease caused by protozoan parasites of the Leishmania genus, transmitted through the bite of infected female sandflies. The disease has diverse clinical presentations, ranging from self-healing cutaneous lesions (localized cutaneous leishmaniasis) to destructive mucocutaneous forms (mucocutaneous leishmaniasis) and potentially fatal visceral leishmaniasis, also known as kala-azar.

The development of an effective vaccine against Leishmania infections is challenging due to the complexity of the parasite's life cycle, genetic diversity, and the variety of clinical outcomes it can cause. Several vaccine candidates have been investigated, primarily focusing on inducing cell-mediated immunity, particularly a Th1 response. These candidates include:

1. First-generation vaccines: These are whole-parasite or live-attenuated vaccines, such as Leishmania major (Lm) strain Friedlin and Leishmania tarentolae. Although these vaccines have shown promising results in animal models, their use in humans is limited due to safety concerns.
2. Second-generation vaccines: These involve subunit or recombinant protein vaccines, which utilize specific antigens from the parasite to stimulate an immune response. Examples include Leishmania antigens such as Leishmania major stress-inducible protein 1 (LiSP1), Leishmania donovani A2, and Leishmania infantum nucleoside hydrolase (LiNH36).
3. Third-generation vaccines: These are DNA or RNA/mRNA vaccines that encode specific antigens from the parasite to stimulate an immune response. Examples include plasmid DNA vaccines encoding Leishmania major HSP70 and Leishmania donovani A2.
4. Adjuvant systems: To enhance the immunogenicity of these vaccine candidates, various adjuvants are being explored, such as saponins (QS-21), cytokines (GM-CSF), and TLR agonists (CpG oligodeoxynucleotides).

Despite significant progress in developing Leishmania vaccines, no licensed vaccine is currently available for human use. Further research is required to optimize the formulation, delivery, and safety of these vaccine candidates to ensure their effectiveness against various Leishmania species and clinical manifestations.

Antimony is a toxic metallic element with the symbol Sb and atomic number 51. It exists in several allotropic forms and can be found naturally as the mineral stibnite. Antimony has been used for centuries in various applications, including medicinal ones, although its use in medicine has largely fallen out of favor due to its toxicity.

In a medical context, antimony may still be encountered in certain medications used to treat parasitic infections, such as pentavalent antimony compounds (e.g., sodium stibogluconate and meglumine antimoniate) for the treatment of leishmaniasis. However, these drugs can have significant side effects and their use is typically reserved for severe cases that cannot be treated with other medications.

It's important to note that exposure to antimony in high concentrations or over prolonged periods can lead to serious health issues, including respiratory problems, skin irritation, gastrointestinal symptoms, and even neurological damage. Therefore, handling antimony-containing substances should be done with caution and appropriate safety measures.

"Phlebotomus" is a genus of sandflies, which are small flies that are known to transmit various diseases such as leishmaniasis. These flies are typically found in warm and humid regions around the world, particularly in the Mediterranean, Middle East, Africa, and Asia. The females of this genus feed on the blood of mammals, including humans, for egg production. It is important to note that not all species of Phlebotomus are vectors of disease, but those that are can cause significant public health concerns in affected areas.

Antimony sodium gluconate is a chemical compound that contains antimony, sodium, and gluconic acid. It is used primarily as a medication to treat the parasitic infection known as leishmaniasis, which is caused by a protozoan parasite and is transmitted through the bite of certain sandflies.

The compound works by inhibiting the growth of the parasite within the host's body. Antimony sodium gluconate is administered intravenously or intramuscularly, depending on the severity of the infection and the patient's overall health status.

It is important to note that antimony sodium gluconate can have significant side effects, including nausea, vomiting, diarrhea, abdominal pain, and muscle weakness. In some cases, it may also cause more serious complications such as cardiac arrhythmias or kidney damage. Therefore, it should only be administered under the close supervision of a healthcare professional.

'Leishmania tropica' is a species of parasitic protozoan that causes cutaneous leishmaniasis, a skin infection commonly known as "Old World" or Middle Eastern form of the disease. The parasite is transmitted to humans through the bite of infected female sandflies, primarily of the genus Phlebotomus in the Old World.

The infection often results in skin ulcers, typically on exposed parts of the body such as the face, arms, and legs. These lesions can be disfiguring and may take several months to heal, leaving scars. In some cases, the infection can spread to other parts of the body, leading to more severe forms of the disease.

The incubation period for cutaneous leishmaniasis caused by Leishmania tropica can range from a few weeks to several months after the sandfly bite. The severity and duration of the disease can vary widely depending on various factors, including the immune status of the infected individual and the specific strain of the parasite.

Preventive measures include using insect repellent, wearing protective clothing, and sleeping under insecticide-treated bed nets in areas where sandflies are prevalent. There is no vaccine available for cutaneous leishmaniasis, but several treatment options are available, including topical treatments, intralesional injections, and systemic medications, depending on the severity of the infection and the patient's overall health condition.

There is no medical definition for "dog diseases" as it is too broad a term. However, dogs can suffer from various health conditions and illnesses that are specific to their species or similar to those found in humans. Some common categories of dog diseases include:

1. Infectious Diseases: These are caused by viruses, bacteria, fungi, or parasites. Examples include distemper, parvovirus, kennel cough, Lyme disease, and heartworms.
2. Hereditary/Genetic Disorders: Some dogs may inherit certain genetic disorders from their parents. Examples include hip dysplasia, elbow dysplasia, progressive retinal atrophy (PRA), and degenerative myelopathy.
3. Age-Related Diseases: As dogs age, they become more susceptible to various health issues. Common age-related diseases in dogs include arthritis, dental disease, cancer, and cognitive dysfunction syndrome (CDS).
4. Nutritional Disorders: Malnutrition or improper feeding can lead to various health problems in dogs. Examples include obesity, malnutrition, and vitamin deficiencies.
5. Environmental Diseases: These are caused by exposure to environmental factors such as toxins, allergens, or extreme temperatures. Examples include heatstroke, frostbite, and toxicities from ingesting harmful substances.
6. Neurological Disorders: Dogs can suffer from various neurological conditions that affect their nervous system. Examples include epilepsy, intervertebral disc disease (IVDD), and vestibular disease.
7. Behavioral Disorders: Some dogs may develop behavioral issues due to various factors such as anxiety, fear, or aggression. Examples include separation anxiety, noise phobias, and resource guarding.

It's important to note that regular veterinary care, proper nutrition, exercise, and preventative measures can help reduce the risk of many dog diseases.

Leishmania guyanensis is a species of protozoan parasite that causes American cutaneous leishmaniasis, a tropical disease transmitted through the bite of infected female sandflies. The disease is characterized by skin lesions that can ulcerate and may leave significant scarring. In some cases, it can also cause more severe forms of the disease, such as mucocutaneous leishmaniasis, which affects the mucous membranes of the nose, mouth, and throat.

The parasite has a complex life cycle that involves two hosts: a mammalian host (such as humans) and an invertebrate host (the sandfly). The parasite exists in two forms during its life cycle: the promastigote form, which is found in the sandfly's gut and is transmitted to the mammalian host through the insect's bite; and the amastigote form, which infects and multiplies within the host's macrophages.

Leishmania guyanensis is found primarily in the rainforests of South America, particularly in French Guiana, Suriname, Guyana, and Brazil. It is estimated that there are around 350 million people at risk of infection with Leishmania parasites worldwide, with an estimated 1.5 to 2 million new cases occurring each year. Prevention measures include using insect repellent, wearing protective clothing, and using bed nets in areas where sandflies are prevalent. Treatment typically involves the use of antiparasitic drugs such as pentavalent antimonials or miltefosine.

"Leishmania major" is a species of parasitic protozoan that causes cutaneous leishmaniasis, a type of disease transmitted through the bite of infected female sandflies. The organism's life cycle involves two main stages: the promastigote stage, which develops in the sandfly vector and is infective to mammalian hosts; and the amastigote stage, which resides inside host cells such as macrophages and dendritic cells, where it replicates.

The disease caused by L. major typically results in skin ulcers or lesions that can take several months to heal and may leave permanent scars. While not usually life-threatening, cutaneous leishmaniasis can cause significant disfigurement and psychological distress, particularly when it affects the face. In addition, people with weakened immune systems, such as those with HIV/AIDS or those undergoing immunosuppressive therapy, may be at risk of developing more severe forms of the disease.

L. major is found primarily in the Old World, including parts of North Africa, the Middle East, and Central Asia. It is transmitted by various species of sandflies belonging to the genus Phlebotomus. Preventive measures include using insect repellent, wearing protective clothing, and reducing outdoor activities during peak sandfly feeding times.

Leishmania mexicana is a species of protozoan parasite that causes cutaneous leishmaniasis, a skin infection, in humans and other mammals. It is transmitted to its hosts through the bite of infected female sandflies, primarily of the genus Lutzomyia. The parasites multiply within the skin lesions of the host, leading to symptoms such as ulcers, scarring, and disfigurement. The severity and duration of the infection can vary widely, and in some cases, the infection may heal on its own without treatment. However, in other cases, the infection can become chronic and lead to significant morbidity.

Leishmania mexicana is found primarily in Mexico and Central America, although it has also been reported in other parts of the world. It is one of several species of Leishmania that can cause cutaneous leishmaniasis, and diagnosis typically involves identifying the parasite through microscopic examination of tissue samples or through molecular testing. Treatment options for cutaneous leishmaniasis caused by L. mexicana include systemic medications such as antimony compounds, miltefosine, and amphotericin B, as well as local treatments such as heat therapy and cryotherapy.

Antigens are substances (usually proteins) found on the surface of cells, or viruses, that can be recognized by the immune system and stimulate an immune response. In the context of protozoa, antigens refer to the specific proteins or other molecules found on the surface of these single-celled organisms that can trigger an immune response in a host organism.

Protozoa are a group of microscopic eukaryotic organisms that include a diverse range of species, some of which can cause diseases in humans and animals. When a protozoan infects a host, the host's immune system recognizes the protozoan antigens as foreign and mounts an immune response to eliminate the infection. This response involves the activation of various types of immune cells, such as T-cells and B-cells, which recognize and target the protozoan antigens.

Understanding the nature of protozoan antigens is important for developing vaccines and other immunotherapies to prevent or treat protozoan infections. For example, researchers have identified specific antigens on the surface of the malaria parasite that are recognized by the human immune system and have used this information to develop vaccine candidates. However, many protozoan infections remain difficult to prevent or treat, and further research is needed to identify new targets for vaccines and therapies.

Antibodies, protozoan, refer to the immune system's response to an infection caused by a protozoan organism. Protozoa are single-celled microorganisms that can cause various diseases in humans, such as malaria, giardiasis, and toxoplasmosis.

When the body is infected with a protozoan, the immune system responds by producing specific proteins called antibodies. Antibodies are produced by a type of white blood cell called a B-cell, and they recognize and bind to specific antigens on the surface of the protozoan organism.

There are five main types of antibodies: IgA, IgD, IgE, IgG, and IgM. Each type of antibody has a different role in the immune response. For example, IgG is the most common type of antibody and provides long-term immunity to previously encountered pathogens. IgM is the first antibody produced in response to an infection and is important for activating the complement system, which helps to destroy the protozoan organism.

Overall, the production of antibodies against protozoan organisms is a critical part of the immune response and helps to protect the body from further infection.

Insect vectors are insects that transmit disease-causing pathogens (such as viruses, bacteria, parasites) from one host to another. They do this while feeding on the host's blood or tissues. The insects themselves are not infected by the pathogen but act as mechanical carriers that pass it on during their bite. Examples of diseases spread by insect vectors include malaria (transmitted by mosquitoes), Lyme disease (transmitted by ticks), and plague (transmitted by fleas). Proper prevention measures, such as using insect repellent and reducing standing water where mosquitoes breed, can help reduce the risk of contracting these diseases.

An endemic disease is a type of disease that is regularly found among particular people or in a certain population, and is spread easily from person to person. The rate of infection is consistently high in these populations, but it is relatively stable and does not change dramatically over time. Endemic diseases are contrasted with epidemic diseases, which suddenly increase in incidence and spread rapidly through a large population.

Endemic diseases are often associated with poverty, poor sanitation, and limited access to healthcare. They can also be influenced by environmental factors such as climate, water quality, and exposure to vectors like mosquitoes or ticks. Examples of endemic diseases include malaria in some tropical countries, tuberculosis (TB) in many parts of the world, and HIV/AIDS in certain populations.

Effective prevention and control measures for endemic diseases typically involve improving access to healthcare, promoting good hygiene and sanitation practices, providing vaccinations when available, and implementing vector control strategies. By addressing the underlying social and environmental factors that contribute to the spread of these diseases, it is possible to reduce their impact on affected populations and improve overall health outcomes.

There doesn't seem to be a specific medical definition for "DNA, protozoan" as it is simply a reference to the DNA found in protozoa. Protozoa are single-celled eukaryotic organisms that can be found in various environments such as soil, water, and the digestive tracts of animals.

Protozoan DNA refers to the genetic material present in these organisms. It is composed of nucleic acids, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), which contain the instructions for the development, growth, and reproduction of the protozoan.

The DNA in protozoa, like in other organisms, is made up of two strands of nucleotides that coil together to form a double helix. The four nucleotide bases that make up protozoan DNA are adenine (A), thymine (T), guanine (G), and cytosine (C). These bases pair with each other to form the rungs of the DNA ladder, with A always pairing with T and G always pairing with C.

The genetic information stored in protozoan DNA is encoded in the sequence of these nucleotide bases. This information is used to synthesize proteins, which are essential for the structure and function of the organism's cells. Protozoan DNA also contains other types of genetic material, such as regulatory sequences that control gene expression and repetitive elements with no known function.

Understanding the DNA of protozoa is important for studying their biology, evolution, and pathogenicity. It can help researchers develop new treatments for protozoan diseases and gain insights into the fundamental principles of genetics and cellular function.

Organometallic compounds are a type of chemical compound that contain at least one metal-carbon bond. This means that the metal is directly attached to carbon atom(s) from an organic molecule. These compounds can be synthesized through various methods, and they have found widespread use in industrial and medicinal applications, including catalysis, polymerization, and pharmaceuticals.

It's worth noting that while organometallic compounds contain metal-carbon bonds, not all compounds with metal-carbon bonds are considered organometallic. For example, in classical inorganic chemistry, simple salts of metal carbonyls (M(CO)n) are not typically classified as organometallic, but rather as metal carbonyl complexes. The distinction between these classes of compounds can sometimes be subtle and is a matter of ongoing debate among chemists.

I apologize, but "Brazil" is not a medical term or condition. It is the largest country in both South America and Latin America by land area and population. If you have any questions related to medical terminology or health concerns, please provide more information and I will do my best to help.

Paromomycin is an antiprotozoal medication, which belongs to the class of aminoglycoside antibiotics. It is primarily used to treat various intestinal infectious diseases caused by protozoa, such as amebiasis (an infection caused by Entamoeba histolytica) and giardiasis (an infection caused by Giardia lamblia). Paromomycin works by inhibiting the protein synthesis in the parasites, leading to their death. It is not typically used to treat bacterial infections in humans, as other aminoglycosides are.

It's important to note that paromomycin has limited systemic absorption and is primarily active within the gastrointestinal tract when taken orally. This makes it a valuable option for treating intestinal parasitic infections without causing significant harm to the beneficial bacteria in the gut or systemically affecting other organs.

Paromomycin is also used in veterinary medicine to treat various protozoal infections in animals, including leishmaniasis in dogs. The medication is available in different forms, such as tablets, capsules, and powder for oral suspension. As with any medication, paromomycin should be taken under the supervision of a healthcare professional, and its use may be subject to specific dosage, frequency, and duration guidelines.

Phosphorylcholine is not a medical condition or disease, but rather a chemical compound. It is the choline ester of phosphoric acid, and it plays an important role in the structure and function of cell membranes. Phosphorylcholine is also found in certain types of lipoproteins, including low-density lipoprotein (LDL) or "bad" cholesterol.

In the context of medical research and therapy, phosphorylcholine has been studied for its potential role in various diseases, such as atherosclerosis, Alzheimer's disease, and other inflammatory conditions. Some studies have suggested that phosphorylcholine may contribute to the development of these diseases by promoting inflammation and immune responses. However, more research is needed to fully understand the role of phosphorylcholine in human health and disease.

The kinetoplast is a unique structure found in the single, mitochondrion of certain protozoan parasites, including those of the genera Trypanosoma and Leishmania. It consists of a network of circular DNA molecules that are highly concentrated and tightly packed. These DNA molecules contain genetic information necessary for the functioning of the unique mitochondrion in these organisms.

The kinetoplast DNA (kDNA) is organized into thousands of maxicircles and minicircles, which vary in size and number depending on the species. Maxicircles are similar to mammalian mitochondrial DNA and encode proteins involved in oxidative phosphorylation, while minicircles contain sequences that code for guide RNAs involved in the editing of maxicircle transcripts.

The kDNA undergoes dynamic rearrangements during the life cycle of these parasites, which involves different morphological and metabolic forms. The study of kDNA has provided valuable insights into the biology and evolution of these important pathogens and has contributed to the development of novel therapeutic strategies.

There is no medical definition for "Protozoan Vaccines" as such because there are currently no licensed vaccines available for human protozoan diseases. Protozoa are single-celled microorganisms that can cause various diseases in humans, such as malaria, toxoplasmosis, and leishmaniasis.

Researchers have been working on developing vaccines against some of these diseases, but none have yet been approved for use in humans. Therefore, it is not possible to provide a medical definition for "Protozoan Vaccines" as a recognized category of vaccines.

Parasite load, in medical terms, refers to the total number or quantity of parasites (such as worms, protozoa, or other infectious agents) present in a host organism's body. It is often used to describe the severity of a parasitic infection and can be an important factor in determining the prognosis and treatment plan for the infected individual.

Parasite load can vary widely depending on the type of parasite, the route of infection, the immune status of the host, and other factors. In some cases, even a small number of parasites may cause significant harm if they are highly virulent or located in critical areas of the body. In other cases, large numbers of parasites may be necessary to produce noticeable symptoms.

Measuring parasite load can be challenging, as it often requires specialized laboratory techniques and equipment. However, accurate assessment of parasite load is important for both research and clinical purposes, as it can help researchers develop more effective treatments and allow healthcare providers to monitor the progression of an infection and evaluate the effectiveness of treatment.

I believe there might be a misunderstanding in your question. "Dogs" is not a medical term or condition. It is the common name for a domesticated carnivore of the family Canidae, specifically the genus Canis, which includes wolves, foxes, and other extant and extinct species of mammals. Dogs are often kept as pets and companions, and they have been bred in a wide variety of forms and sizes for different purposes, such as hunting, herding, guarding, assisting police and military forces, and providing companionship and emotional support.

If you meant to ask about a specific medical condition or term related to dogs, please provide more context so I can give you an accurate answer.

I'm sorry for any confusion, but "Sudan" is not a medical term. It is a country located in Northeast Africa, known as the Sudan or Sudan proper, and the southern region that seceded to become South Sudan in 2011. If you have any medical terms you would like me to define, please let me know!

Amphotericin B is an antifungal medication used to treat serious and often life-threatening fungal infections. It works by binding to the ergosterol in the fungal cell membrane, creating pores that lead to the loss of essential cell components and ultimately cell death.

The medical definition of Amphotericin B is:

A polyene antifungal agent derived from Streptomyces nodosus, with a broad spectrum of activity against various fungi, including Candida, Aspergillus, Cryptococcus, and Histoplasma capsulatum. Amphotericin B is used to treat systemic fungal infections, such as histoplasmosis, cryptococcosis, candidiasis, and aspergillosis, among others. It may be administered intravenously or topically, depending on the formulation and the site of infection.

Adverse effects associated with Amphotericin B include infusion-related reactions (such as fever, chills, and hypotension), nephrotoxicity, electrolyte imbalances, and anemia. These side effects are often dose-dependent and may be managed through careful monitoring and adjustment of the dosing regimen.

A disease reservoir refers to a population or group of living organisms, including humans, animals, and even plants, that can naturally carry and transmit a particular pathogen (disease-causing agent) without necessarily showing symptoms of the disease themselves. These hosts serve as a source of infection for other susceptible individuals, allowing the pathogen to persist and circulate within a community or environment.

Disease reservoirs can be further classified into:

1. **Primary (or Main) Reservoir**: This refers to the species that primarily harbors and transmits the pathogen, contributing significantly to its natural ecology and maintaining its transmission cycle. For example, mosquitoes are the primary reservoirs for many arboviruses like dengue, Zika, and chikungunya viruses.

2. **Amplifying Hosts**: These hosts can become infected with the pathogen and experience a high rate of replication, leading to an increased concentration of the pathogen in their bodies. This allows for efficient transmission to other susceptible hosts or vectors. For instance, birds are amplifying hosts for West Nile virus, as they can become viremic (have high levels of virus in their blood) and infect feeding mosquitoes that then transmit the virus to other animals and humans.

3. **Dead-end Hosts**: These hosts may become infected with the pathogen but do not contribute significantly to its transmission cycle, as they either do not develop sufficient quantities of the pathogen to transmit it or do not come into contact with potential vectors or susceptible hosts. For example, humans are dead-end hosts for many zoonotic diseases like rabies, as they cannot transmit the virus to other humans.

Understanding disease reservoirs is crucial in developing effective strategies for controlling and preventing infectious diseases, as it helps identify key species and environments that contribute to their persistence and transmission.

'Insect control' is not a term typically used in medical definitions. However, it generally refers to the methods and practices used to manage or reduce the population of insects that can be harmful or disruptive to human health, food supply, or property. This can include various strategies such as chemical pesticides, biological control agents, habitat modification, and other integrated pest management techniques.

In medical terms, 'vector control' is a more relevant concept, which refers to the specific practices used to reduce or prevent the transmission of infectious diseases by insects and other arthropods that act as disease vectors (such as mosquitoes, ticks, and fleas). Vector control measures may include the use of insecticides, larvicides, biological control agents, environmental management, personal protection methods, and other integrated vector management strategies.

I'm sorry for any confusion, but "Venezuela" is not a medical term. It is the name of a country located in South America, known officially as the Bolivarian Republic of Venezuela. If you have any questions about medical terms or health-related topics, I would be happy to try and help answer those for you!

Parasitology is a branch of biology that deals with the study of parasites, their life cycles, the relationship between parasites and their hosts, the transmission of parasitic diseases, and the development of methods for their control and elimination. It involves understanding various types of parasites including protozoa, helminths, and arthropods that can infect humans, animals, and plants. Parasitologists also study the evolution, genetics, biochemistry, and ecology of parasites to develop effective strategies for their diagnosis, treatment, and prevention.

Pentamidine is an antimicrobial drug that is primarily used to treat and prevent certain types of pneumonia caused by the parasitic organisms Pneumocystis jirovecii (formerly known as P. carinii) and Leishmania donovani. It can also be used for the treatment of some fungal infections caused by Histoplasma capsulatum and Cryptococcus neoformans.

Pentamidine works by interfering with the DNA replication and protein synthesis of these microorganisms, which ultimately leads to their death. It is available as an injection or inhaled powder for medical use. Common side effects of pentamidine include nausea, vomiting, diarrhea, abdominal pain, and changes in blood sugar levels. More serious side effects can include kidney damage, hearing loss, and heart rhythm disturbances.

It is important to note that the use of pentamidine should be under the supervision of a healthcare professional due to its potential for serious side effects and drug interactions.

I'm sorry for any confusion, but "India" is not a medical term or concept. It is a country in South Asia, the second-most populous country in the world, known for its rich history, diverse culture, and numerous contributions to various fields including medicine. If you have any questions related to medical topics, I would be happy to help answer them!

BALB/c is an inbred strain of laboratory mouse that is widely used in biomedical research. The strain was developed at the Institute of Cancer Research in London by Henry Baldwin and his colleagues in the 1920s, and it has since become one of the most commonly used inbred strains in the world.

BALB/c mice are characterized by their black coat color, which is determined by a recessive allele at the tyrosinase locus. They are also known for their docile and friendly temperament, making them easy to handle and work with in the laboratory.

One of the key features of BALB/c mice that makes them useful for research is their susceptibility to certain types of tumors and immune responses. For example, they are highly susceptible to developing mammary tumors, which can be induced by chemical carcinogens or viral infection. They also have a strong Th2-biased immune response, which makes them useful models for studying allergic diseases and asthma.

BALB/c mice are also commonly used in studies of genetics, neuroscience, behavior, and infectious diseases. Because they are an inbred strain, they have a uniform genetic background, which makes it easier to control for genetic factors in experiments. Additionally, because they have been bred in the laboratory for many generations, they are highly standardized and reproducible, making them ideal subjects for scientific research.

I'm sorry for any confusion, but "Protozoan Proteins" is not a specific medical or scientific term. Protozoa are single-celled eukaryotic organisms, and proteins are large biological molecules consisting of one or more chains of amino acid residues. Therefore, "Protozoan Proteins" generally refers to the various types of proteins found in protozoa.

However, if you're looking for information about proteins specific to certain protozoan parasites with medical relevance (such as Plasmodium falciparum, which causes malaria), I would be happy to help! Please provide more context or specify the particular protozoan of interest.

I apologize for any confusion, but "Colombia" is not a medical term. It is the name of a country located in South America, known officially as the Republic of Colombia. If you are looking for medical information related to Colombia or its healthcare system, I would be happy to try to help you with that.

I apologize for any confusion, but "Argentina" is a country in South America and not a medical term or concept. The term "argyria" may be what you're looking for, which is a rare condition resulting from the accumulation of silver compounds in the body, causing the skin to turn blue-gray. However, Argentina and argyria are two distinct terms with different meanings.

A skin ulcer is a defined as a loss of continuity or disruption of the skin surface, often accompanied by inflammation and/or infection. These lesions can result from various causes including pressure, venous or arterial insufficiency, diabetes, and chronic dermatological conditions. Skin ulcers are typically characterized by their appearance, depth, location, and underlying cause. Common types of skin ulcers include pressure ulcers (also known as bedsores), venous leg ulcers, arterial ulcers, and diabetic foot ulcers. Proper evaluation, wound care, management of underlying conditions, and prevention strategies are crucial in the treatment of skin ulcers to promote healing and prevent complications.

A disease vector is a living organism that transmits infectious pathogens from one host to another. These vectors can include mosquitoes, ticks, fleas, and other arthropods that carry viruses, bacteria, parasites, or other disease-causing agents. The vector becomes infected with the pathogen after biting an infected host, and then transmits the infection to another host through its saliva or feces during a subsequent blood meal.

Disease vectors are of particular concern in public health because they can spread diseases rapidly and efficiently, often over large geographic areas. Controlling vector-borne diseases requires a multifaceted approach that includes reducing vector populations, preventing bites, and developing vaccines or treatments for the associated diseases.

Serologic tests are laboratory tests that detect the presence or absence of antibodies or antigens in a patient's serum (the clear liquid that separates from clotted blood). These tests are commonly used to diagnose infectious diseases, as well as autoimmune disorders and other medical conditions.

In serologic testing for infectious diseases, a sample of the patient's blood is collected and allowed to clot. The serum is then separated from the clot and tested for the presence of antibodies that the body has produced in response to an infection. The test may be used to identify the specific type of infection or to determine whether the infection is active or has resolved.

Serologic tests can also be used to diagnose autoimmune disorders, such as rheumatoid arthritis and lupus, by detecting the presence of antibodies that are directed against the body's own tissues. These tests can help doctors confirm a diagnosis and monitor the progression of the disease.

It is important to note that serologic tests are not always 100% accurate and may produce false positive or false negative results. Therefore, they should be interpreted in conjunction with other clinical findings and laboratory test results.

Sensitivity and specificity are statistical measures used to describe the performance of a diagnostic test or screening tool in identifying true positive and true negative results.

* Sensitivity refers to the proportion of people who have a particular condition (true positives) who are correctly identified by the test. It is also known as the "true positive rate" or "recall." A highly sensitive test will identify most or all of the people with the condition, but may also produce more false positives.
* Specificity refers to the proportion of people who do not have a particular condition (true negatives) who are correctly identified by the test. It is also known as the "true negative rate." A highly specific test will identify most or all of the people without the condition, but may also produce more false negatives.

In medical testing, both sensitivity and specificity are important considerations when evaluating a diagnostic test. High sensitivity is desirable for screening tests that aim to identify as many cases of a condition as possible, while high specificity is desirable for confirmatory tests that aim to rule out the condition in people who do not have it.

It's worth noting that sensitivity and specificity are often influenced by factors such as the prevalence of the condition in the population being tested, the threshold used to define a positive result, and the reliability and validity of the test itself. Therefore, it's important to consider these factors when interpreting the results of a diagnostic test.

Skin tests are medical diagnostic procedures that involve the application of a small amount of a substance to the skin, usually through a scratch, prick, or injection, to determine if the body has an allergic reaction to it. The most common type of skin test is the patch test, which involves applying a patch containing a small amount of the suspected allergen to the skin and observing the area for signs of a reaction, such as redness, swelling, or itching, over a period of several days. Another type of skin test is the intradermal test, in which a small amount of the substance is injected just beneath the surface of the skin. Skin tests are used to help diagnose allergies, including those to pollen, mold, pets, and foods, as well as to identify sensitivities to medications, chemicals, and other substances.

I'm sorry for any confusion, but "Nepal" is not a medical term. It is a country located in South Asia, between China and India. If you have any questions about medical terminology or health-related topics, I would be happy to try and help answer those for you.

Polymerase Chain Reaction (PCR) is a laboratory technique used to amplify specific regions of DNA. It enables the production of thousands to millions of copies of a particular DNA sequence in a rapid and efficient manner, making it an essential tool in various fields such as molecular biology, medical diagnostics, forensic science, and research.

The PCR process involves repeated cycles of heating and cooling to separate the DNA strands, allow primers (short sequences of single-stranded DNA) to attach to the target regions, and extend these primers using an enzyme called Taq polymerase, resulting in the exponential amplification of the desired DNA segment.

In a medical context, PCR is often used for detecting and quantifying specific pathogens (viruses, bacteria, fungi, or parasites) in clinical samples, identifying genetic mutations or polymorphisms associated with diseases, monitoring disease progression, and evaluating treatment effectiveness.

Zoonoses are infectious diseases that can be transmitted from animals to humans. They are caused by pathogens such as viruses, bacteria, parasites, or fungi that naturally infect non-human animals and can sometimes infect and cause disease in humans through various transmission routes like direct contact with infected animals, consumption of contaminated food or water, or vectors like insects. Some well-known zoonotic diseases include rabies, Lyme disease, salmonellosis, and COVID-19 (which is believed to have originated from bats). Public health officials work to prevent and control zoonoses through various measures such as surveillance, education, vaccination, and management of animal populations.

Agglutination tests are laboratory diagnostic procedures used to detect the presence of antibodies or antigens in a sample, such as blood or serum. These tests work by observing the clumping (agglutination) of particles, like red blood cells or bacteriophages, coated with specific antigens or antibodies when mixed with a patient's sample.

In an agglutination test, the sample is typically combined with a reagent containing known antigens or antibodies on the surface of particles, such as latex beads, red blood cells, or bacteriophages. If the sample contains the corresponding antibodies or antigens, they will bind to the particles, forming visible clumps or agglutinates. The presence and strength of agglutination are then assessed visually or with automated equipment to determine the presence and quantity of the target antigen or antibody in the sample.

Agglutination tests are widely used in medical diagnostics for various applications, including:

1. Bacterial and viral infections: To identify specific bacterial or viral antigens in a patient's sample, such as group A Streptococcus, Legionella pneumophila, or HIV.
2. Blood typing: To determine the ABO blood group and Rh type of a donor or recipient before a blood transfusion or organ transplantation.
3. Autoimmune diseases: To detect autoantibodies in patients with suspected autoimmune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, or Hashimoto's thyroiditis.
4. Allergies: To identify specific IgE antibodies in a patient's sample to determine allergic reactions to various substances, such as pollen, food, or venom.
5. Drug monitoring: To detect and quantify the presence of drug-induced antibodies, such as those developed in response to penicillin or hydralazine therapy.

Agglutination tests are simple, rapid, and cost-effective diagnostic tools that provide valuable information for clinical decision-making and patient management. However, they may have limitations, including potential cross-reactivity with other antigens, false-positive results due to rheumatoid factors or heterophile antibodies, and false-negative results due to the prozone effect or insufficient sensitivity. Therefore, it is essential to interpret agglutination test results in conjunction with clinical findings and other laboratory data.

I'm sorry for any confusion, but "Bolivia" is not a medical term or concept. It is the name of a country located in South America, known officially as the Plurinational State of Bolivia. If you have any questions related to geography, history, or culture, I would be happy to try and help with those. However, for medical advice or information, it's always best to consult a qualified healthcare professional.

I'm sorry for any confusion, but "Peru" is not a medical term. It is a country located in South America, known for its rich history, diverse culture, and beautiful landscapes. If you have any questions about medical terms or concepts, I would be happy to help answer those!

In medical terms, the skin is the largest organ of the human body. It consists of two main layers: the epidermis (outer layer) and dermis (inner layer), as well as accessory structures like hair follicles, sweat glands, and oil glands. The skin plays a crucial role in protecting us from external factors such as bacteria, viruses, and environmental hazards, while also regulating body temperature and enabling the sense of touch.

Interferon-gamma (IFN-γ) is a soluble cytokine that is primarily produced by the activation of natural killer (NK) cells and T lymphocytes, especially CD4+ Th1 cells and CD8+ cytotoxic T cells. It plays a crucial role in the regulation of the immune response against viral and intracellular bacterial infections, as well as tumor cells. IFN-γ has several functions, including activating macrophages to enhance their microbicidal activity, increasing the presentation of major histocompatibility complex (MHC) class I and II molecules on antigen-presenting cells, stimulating the proliferation and differentiation of T cells and NK cells, and inducing the production of other cytokines and chemokines. Additionally, IFN-γ has direct antiproliferative effects on certain types of tumor cells and can enhance the cytotoxic activity of immune cells against infected or malignant cells.

Benzethonium is an antimicrobial agent used as a preservative in some pharmaceutical and cosmetic products. It has broad-spectrum activity against gram-positive and gram-negative bacteria, fungi, and viruses. The chemical name for benzethonium chloride is N'-(1-benzyl-4-phenoxypyridinio) decane methosulfate.

Benzethonium chloride is commonly used as a topical antiseptic in products such as skin cleansers, hand sanitizers, and first aid treatments. It works by disrupting the bacterial cell membrane, leading to the death of the microorganism. However, it may not be effective against some spores and highly resistant bacteria.

It is important to note that benzethonium chloride should be used according to the instructions on the product label and should not be ingested or used in the eyes or mucous membranes unless specifically directed by a healthcare professional.

An Enzyme-Linked Immunosorbent Assay (ELISA) is a type of analytical biochemistry assay used to detect and quantify the presence of a substance, typically a protein or peptide, in a liquid sample. It takes its name from the enzyme-linked antibodies used in the assay.

In an ELISA, the sample is added to a well containing a surface that has been treated to capture the target substance. If the target substance is present in the sample, it will bind to the surface. Next, an enzyme-linked antibody specific to the target substance is added. This antibody will bind to the captured target substance if it is present. After washing away any unbound material, a substrate for the enzyme is added. If the enzyme is present due to its linkage to the antibody, it will catalyze a reaction that produces a detectable signal, such as a color change or fluorescence. The intensity of this signal is proportional to the amount of target substance present in the sample, allowing for quantification.

ELISAs are widely used in research and clinical settings to detect and measure various substances, including hormones, viruses, and bacteria. They offer high sensitivity, specificity, and reproducibility, making them a reliable choice for many applications.

I'm sorry for any confusion, but "population density" is actually a term used in population geography and epidemiology, rather than medical terminology. It refers to the number of people living in a specific area or region, usually measured as the number of people per square mile or square kilometer.

However, understanding population density can be important in public health and medicine because it can influence various factors related to health outcomes and healthcare delivery, such as:

1. Disease transmission rates: Higher population densities can facilitate the spread of infectious diseases, particularly those that are transmitted through close contact between individuals.
2. Access to healthcare services: Areas with lower population density might have fewer healthcare resources and providers available, making it more challenging for residents to access necessary medical care.
3. Health disparities: Population density can contribute to health inequities, as urban areas often have better access to healthcare, education, and economic opportunities than rural areas, leading to differences in health outcomes between these populations.
4. Environmental factors: Higher population densities might lead to increased pollution, noise, and other environmental hazards that can negatively impact health.

Therefore, while "population density" is not a medical definition per se, it remains an essential concept for understanding various public health and healthcare issues.

Euglenozoa is a group of unicellular organisms that includes both free-living and parasitic species. Two major parasitic groups within Euglenozoa are the kinetoplastids, which include organisms such as Trypanosoma and Leishmania, and the diplonemids.

Trypanosoma infections can cause diseases such as African sleeping sickness (also known as human African trypanosomiasis) and Chagas disease (also known as American trypanosomiasis), while Leishmania infections can cause various forms of leishmaniasis, including cutaneous, mucocutaneous, and visceral leishmaniasis. These diseases are transmitted to humans through the bites of infected insect vectors, such as tsetse flies (in the case of African sleeping sickness) or sandflies (in the case of leishmaniasis and Chagas disease).

Diplonemid infections in humans have not been well-studied, and it is currently unclear whether these organisms are capable of causing disease in humans. However, diplonemids have been found to infect a wide range of marine and freshwater organisms, including fish, crustaceans, and other protists.

In general, euglenozoan infections can cause a variety of symptoms depending on the specific organism involved and the location of the infection within the body. Symptoms may include fever, swelling, skin lesions, anemia, and damage to various organs. Treatment for these infections typically involves the use of antiparasitic drugs, such as pentamidine, suramin, or benznidazole, although the specific treatment approach will depend on the organism involved and the severity of the infection.

Parasitic sensitivity tests, also known as parasite drug susceptibility tests, refer to laboratory methods used to determine the effectiveness of specific antiparasitic medications against a particular parasitic infection. These tests help healthcare providers identify which drugs are most likely to be effective in treating an individual's infection and which ones should be avoided due to resistance or increased risk of side effects.

There are several types of parasitic sensitivity tests, including:

1. In vitro susceptibility testing: This involves culturing the parasite in a laboratory setting and exposing it to different concentrations of antiparasitic drugs. The growth or survival of the parasite is then observed and compared to a control group that was not exposed to the drug. This helps identify the minimum inhibitory concentration (MIC) of the drug, which is the lowest concentration required to prevent the growth of the parasite.
2. Molecular testing: This involves analyzing the genetic material of the parasite to detect specific mutations or gene variations that are associated with resistance to certain antiparasitic drugs. This type of testing can be performed using a variety of methods, including polymerase chain reaction (PCR) and DNA sequencing.
3. Phenotypic testing: This involves observing the effects of antiparasitic drugs on the growth or survival of the parasite in a laboratory setting. For example, a parasite may be grown in a culture medium and then exposed to different concentrations of a drug. The growth of the parasite is then monitored over time to determine the drug's effectiveness.

Parasitic sensitivity tests are important for guiding the treatment of many parasitic infections, including malaria, tuberculosis, and leishmaniasis. These tests can help healthcare providers choose the most effective antiparasitic drugs for their patients, reduce the risk of drug resistance, and improve treatment outcomes.

Trypanocidal agents are a type of medication specifically used for the treatment and prevention of trypanosomiasis, which is a group of diseases caused by various species of protozoan parasites belonging to the genus Trypanosoma. These agents work by killing or inhibiting the growth of the parasites in the human body.

There are two main types of human trypanosomiasis: African trypanosomiasis, also known as sleeping sickness, which is caused by Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense; and American trypanosomiasis, also known as Chagas disease, which is caused by Trypanosoma cruzi.

Trypanocidal agents can be divided into two categories:

1. Drugs used to treat African trypanosomiasis: These include pentamidine, suramin, melarsoprol, and eflornithine. Pentamidine and suramin are used for the early stages of the disease, while melarsoprol and eflornithine are used for the later stages.
2. Drugs used to treat American trypanosomiasis: The main drug used for Chagas disease is benznidazole, which is effective in killing the parasites during the acute phase of the infection. Another drug, nifurtimox, can also be used, although it has more side effects than benznidazole.

It's important to note that trypanocidal agents have limited availability and are often associated with significant toxicity, making their use challenging in some settings. Therefore, prevention measures such as avoiding insect vectors and using vector control methods remain crucial in controlling the spread of these diseases.

Neglected Tropical Diseases (NTDs) are a group of infectious diseases that primarily affect people living in poverty, in tropical and subtropical areas. These diseases are called "neglected" because they have been largely ignored by medical research and drug development, as well as by global health agencies and pharmaceutical companies.

The World Health Organization (WHO) has identified 20 diseases as NTDs, including:

1. Buruli ulcer
2. Chagas disease
3. Dengue and chikungunya
4. Dracunculiasis (guinea-worm disease)
5. Echinococcosis
6. Endemic treponematoses
7. Foodborne trematodiases
8. Human African trypanosomiasis (sleeping sickness)
9. Leishmaniasis
10. Leprosy (Hansen's disease)
11. Lymphatic filariasis
12. Onchocerciasis (river blindness)
13. Rabies
14. Schistosomiasis
15. Soil-transmitted helminthiases
16. Snakebite envenoming
17. Taeniasis/Cysticercosis
18. Trachoma
19. Mycetoma, chromoblastomycosis and other deep mycoses
20. Yaws (Endemic treponematoses)

These diseases can lead to severe disfigurement, disability, and even death if left untreated. They affect more than 1 billion people worldwide, mainly in low-income countries in Africa, Asia, and the Americas. NTDs also have significant social and economic impacts, contributing to poverty, stigma, discrimination, and exclusion.

Efforts are underway to raise awareness and increase funding for research, prevention, and treatment of NTDs. The WHO has set targets for controlling or eliminating several NTDs by 2030, including dracunculiasis, lymphatic filariasis, onchocerciasis, trachoma, and human African trypanosomiasis.

I'm sorry for any confusion, but "Panama" is not a medical term. It is a country located in Central America, known for its famous canal and diverse wildlife. If you have any questions about medical terms or conditions, I would be happy to help answer those!

Medical geography, also known as health geography, is a branch of both human and physical geography that focuses on the spatial aspects of health and disease. It is an interdisciplinary field that incorporates concepts from epidemiology, medical sociology, public health, and health services research to examine the distribution, determinants, and patterns of health and disease in human populations.

Medical geographers study a variety of topics related to health, including environmental hazards, access to healthcare, infectious diseases, chronic conditions, and health disparities. They use spatial analysis techniques, such as geographic information systems (GIS) and spatial statistics, to map and analyze the geographical patterns of health outcomes and determinants.

Medical geography has important applications in public health policy and planning, including identifying areas with high rates of disease or limited access to healthcare, developing targeted interventions to address health disparities, and evaluating the effectiveness of public health programs.

Immunochromatography is a rapid and qualitative diagnostic assay that involves the use of immunological reagents, such as antibodies or antigens, to detect the presence or absence of a specific analyte in a sample. It is a type of chromatographic technique that utilizes the properties of antigen-antibody interactions for the detection and quantification of various analytes, including proteins, hormones, drugs, and infectious agents.

The assay typically involves the application of a sample to a porous membrane strip that contains immobilized antibodies or antigens at specific locations. As the sample migrates along the membrane by capillary action, it interacts with these reagents, leading to the formation of visible bands or lines that indicate the presence or absence of the target analyte.

One common type of immunochromatography is lateral flow assay (LFA), which is widely used in point-of-care testing for various applications, such as pregnancy tests, drug screening, and infectious disease diagnosis. LFAs are simple to use, do not require specialized equipment or technical expertise, and provide rapid results within a few minutes.

Overall, immunochromatography is a valuable tool in clinical diagnostics, providing a fast and reliable method for the detection of various analytes in a wide range of samples.

I'm sorry for any confusion, but "Hyraxes" is not a medical term. Hyraxes are small, mammalian herbivores that belong to the family Procaviidae and order Hyracoidea. They are native to Africa and the Middle East. If you have any questions about animals or a different topic, I'd be happy to try and help with those!

'Afghanistan' is a country and not a medical term or condition. It is located in Central Asia and is bordered by Pakistan, Iran, Turkmenistan, Uzbekistan, Tajikistan, China, and the Arabian Sea. The country has a complex history with ongoing political and security challenges. If you are looking for information related to medical tourism or healthcare in Afghanistan, I can provide some general insights. However, please note that the medical facilities and services in Afghanistan may not be comparable to those in developed countries due to various factors such as infrastructure, resources, and expertise.

"Mesocricetus" is a genus of rodents, more commonly known as hamsters. It includes several species of hamsters that are native to various parts of Europe and Asia. The best-known member of this genus is the Syrian hamster, also known as the golden hamster or Mesocricetus auratus, which is a popular pet due to its small size and relatively easy care. These hamsters are burrowing animals and are typically solitary in the wild.

I'm sorry for any confusion, but "Tunisia" is not a medical term. It is actually the name of a country located in North Africa, known for its rich history, beautiful coastline, and vibrant culture. If you have any questions about medical terms or if there's another topic you'd like to know more about, please let me know!

"Rodentia" is not a medical term, but a taxonomic category in biology. It refers to the largest order of mammals, comprising over 40% of all mammal species. Commonly known as rodents, this group includes mice, rats, hamsters, gerbils, guinea pigs, squirrels, prairie dogs, capybaras, beavers, and many others.

While "Rodentia" itself is not a medical term, certain conditions or issues related to rodents can have medical implications. For instance, rodents are known to carry and transmit various diseases that can affect humans, such as hantavirus, leptospirosis, salmonellosis, and lymphocytic choriomeningitis (LCMV). Therefore, understanding the biology and behavior of rodents is important in the context of public health and preventive medicine.

Interleukin-10 (IL-10) is an anti-inflammatory cytokine that plays a crucial role in the modulation of immune responses. It is produced by various cell types, including T cells, macrophages, and dendritic cells. IL-10 inhibits the production of pro-inflammatory cytokines, such as TNF-α, IL-1, IL-6, IL-8, and IL-12, and downregulates the expression of costimulatory molecules on antigen-presenting cells. This results in the suppression of T cell activation and effector functions, which ultimately helps to limit tissue damage during inflammation and promote tissue repair. Dysregulation of IL-10 has been implicated in various pathological conditions, including chronic infections, autoimmune diseases, and cancer.

I'm sorry for any confusion, but "seasons" is not a term that has a medical definition. Seasons refer to the four divisions of the year (spring, summer, autumn or fall, and winter) based on the position of the earth in its orbit around the sun. If you have any questions related to health or medicine, I'd be happy to try to help answer those!

Intradermal tests are a type of allergy test that involves the injection of a small amount of allergen extract directly into the skin, usually the forearm or back. This is different from other types of allergy tests such as scratch tests or blood tests, which measure immune system responses to allergens in other ways.

During an intradermal test, a healthcare professional uses a fine needle to inject a small amount of allergen extract just beneath the surface of the skin. This creates a small wheal or bubble, and the area is then observed for signs of a reaction such as redness, swelling, or itching. These reactions indicate that the person has antibodies to the allergen and may be allergic to it.

Intradermal tests are often used when other types of allergy tests have been inconclusive or when a healthcare professional wants to confirm the results of a previous test. They can be used to diagnose a variety of allergies, including those to insect venom, medications, and environmental allergens such as pollen or mold.

It's important to note that intradermal tests carry a higher risk of causing a severe allergic reaction than other types of allergy tests, so they should only be performed by trained healthcare professionals in a medical setting where appropriate treatments are available.

I must clarify that "Ethiopia" is not a medical term or condition. Ethiopia is a country located in the Horn of Africa, known for its rich history and cultural heritage. It is the second-most populous nation in Africa, with diverse ethnic groups, languages, and religious practices.

If you have any questions related to medical terminology or health-related topics, please feel free to ask! I'm here to help.

I'm sorry for any confusion, but "Iran" is not a medical term or concept. It is the name of a country located in southwest Asia. If you have any questions about medical terminology or health-related topics, I would be happy to try and help answer them!

The Fluorescent Antibody Technique (FAT), Indirect is a type of immunofluorescence assay used to detect the presence of specific antigens in a sample. In this method, the sample is first incubated with a primary antibody that binds to the target antigen. After washing to remove unbound primary antibodies, a secondary fluorescently labeled antibody is added, which recognizes and binds to the primary antibody. This indirect labeling approach allows for amplification of the signal, making it more sensitive than direct methods. The sample is then examined under a fluorescence microscope to visualize the location and amount of antigen based on the emitted light from the fluorescent secondary antibody. It's commonly used in diagnostic laboratories for detection of various bacteria, viruses, and other antigens in clinical specimens.

Macrophages are a type of white blood cell that are an essential part of the immune system. They are large, specialized cells that engulf and destroy foreign substances, such as bacteria, viruses, parasites, and fungi, as well as damaged or dead cells. Macrophages are found throughout the body, including in the bloodstream, lymph nodes, spleen, liver, lungs, and connective tissues. They play a critical role in inflammation, immune response, and tissue repair and remodeling.

Macrophages originate from monocytes, which are a type of white blood cell produced in the bone marrow. When monocytes enter the tissues, they differentiate into macrophages, which have a larger size and more specialized functions than monocytes. Macrophages can change their shape and move through tissues to reach sites of infection or injury. They also produce cytokines, chemokines, and other signaling molecules that help coordinate the immune response and recruit other immune cells to the site of infection or injury.

Macrophages have a variety of surface receptors that allow them to recognize and respond to different types of foreign substances and signals from other cells. They can engulf and digest foreign particles, bacteria, and viruses through a process called phagocytosis. Macrophages also play a role in presenting antigens to T cells, which are another type of immune cell that helps coordinate the immune response.

Overall, macrophages are crucial for maintaining tissue homeostasis, defending against infection, and promoting wound healing and tissue repair. Dysregulation of macrophage function has been implicated in a variety of diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions.

I'm sorry for any confusion, but "Military Facilities" is not a term that has a specific medical definition. Military facilities generally refer to buildings, land, and infrastructure used by military forces for various purposes, such as training, housing troops, manufacturing weapons, or storing military equipment. It does not fall under the purview of medical definitions. If you have any questions related to medical terminology, I would be happy to help!

I apologize for any confusion, but "Ecuador" is not a medical term or concept. It is the name of a country located in South America, officially known as the "República del Ecuador." If you have any questions related to medicine or health, I would be happy to try and help answer those for you!

The spleen is an organ in the upper left side of the abdomen, next to the stomach and behind the ribs. It plays multiple supporting roles in the body:

1. It fights infection by acting as a filter for the blood. Old red blood cells are recycled in the spleen, and platelets and white blood cells are stored there.
2. The spleen also helps to control the amount of blood in the body by removing excess red blood cells and storing platelets.
3. It has an important role in immune function, producing antibodies and removing microorganisms and damaged red blood cells from the bloodstream.

The spleen can be removed without causing any significant problems, as other organs take over its functions. This is known as a splenectomy and may be necessary if the spleen is damaged or diseased.

I'm sorry for any confusion, but "Suriname" is not a medical term. It is a country located in South America, known for its diverse culture and rich biodiversity. If you have any questions about medical terminology or Surinamese health issues, I would be happy to try to help answer those!

Th1 cells, or Type 1 T helper cells, are a subset of CD4+ T cells that play a crucial role in the cell-mediated immune response. They are characterized by the production of specific cytokines, such as interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and interleukin-2 (IL-2). Th1 cells are essential for protecting against intracellular pathogens, including viruses, bacteria, and parasites. They activate macrophages to destroy ingested microorganisms, stimulate the differentiation of B cells into plasma cells that produce antibodies, and recruit other immune cells to the site of infection. Dysregulation of Th1 cell responses has been implicated in various autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis, and type 1 diabetes.

Asymptomatic infections are those in which an individual carries and may transmit a pathogen, such as a virus or bacteria, but does not develop any symptoms associated with the infection. These individuals are often referred to as being "asymptomatically infected" or "asymptomatic carriers."

Asymptomatic infections can occur with various infectious diseases, including COVID-19, HIV, hepatitis B, and some sexually transmitted infections. In many cases, asymptomatic individuals may not realize they are infected and unknowingly transmit the pathogen to others. This makes identifying and controlling asymptomatic infections crucial for preventing outbreaks and limiting the spread of infectious diseases.

It's important to note that while asymptomatic individuals do not experience symptoms, they can still develop immunity to the infection, similar to those who experienced symptoms. Additionally, some asymptomatic infections may progress to symptomatic illness over time or upon subsequent exposures to the pathogen.

Insect bites and stings refer to the penetration of the skin by insects, such as mosquitoes, fleas, ticks, or bees, often resulting in localized symptoms including redness, swelling, itching, and pain. The reaction can vary depending on the individual's sensitivity and the type of insect. In some cases, systemic reactions like anaphylaxis may occur, which requires immediate medical attention. Treatment typically involves relieving symptoms with topical creams, antihistamines, or in severe cases, epinephrine. Prevention measures include using insect repellent and protective clothing.

Immunoglobulin G (IgG) is a type of antibody, which is a protective protein produced by the immune system in response to foreign substances like bacteria or viruses. IgG is the most abundant type of antibody in human blood, making up about 75-80% of all antibodies. It is found in all body fluids and plays a crucial role in fighting infections caused by bacteria, viruses, and toxins.

IgG has several important functions:

1. Neutralization: IgG can bind to the surface of bacteria or viruses, preventing them from attaching to and infecting human cells.
2. Opsonization: IgG coats the surface of pathogens, making them more recognizable and easier for immune cells like neutrophils and macrophages to phagocytose (engulf and destroy) them.
3. Complement activation: IgG can activate the complement system, a group of proteins that work together to help eliminate pathogens from the body. Activation of the complement system leads to the formation of the membrane attack complex, which creates holes in the cell membranes of bacteria, leading to their lysis (destruction).
4. Antibody-dependent cellular cytotoxicity (ADCC): IgG can bind to immune cells like natural killer (NK) cells and trigger them to release substances that cause target cells (such as virus-infected or cancerous cells) to undergo apoptosis (programmed cell death).
5. Immune complex formation: IgG can form immune complexes with antigens, which can then be removed from the body through various mechanisms, such as phagocytosis by immune cells or excretion in urine.

IgG is a critical component of adaptive immunity and provides long-lasting protection against reinfection with many pathogens. It has four subclasses (IgG1, IgG2, IgG3, and IgG4) that differ in their structure, function, and distribution in the body.

I'm sorry for any confusion, but "Bangladesh" is a country located in South Asia, rather than a medical term or condition. It is bordered by India to the west, north, and east, and by Myanmar (Burma) to the southeast, with the Bay of Bengal to the south. The official name of the country is the People's Republic of Bangladesh.

If you have any questions related to medical terminology or health-related topics, I would be happy to help answer them for you!

Medical topography refers to the detailed description and mapping of the locations and relative positions of various anatomical structures, abnormalities, or lesions in the body. It is often used in the context of imaging techniques such as X-rays, CT scans, or MRI scans, where it helps to visualize and communicate the spatial relationships between different bodily features. Medical topography may also involve the use of physical examination, surgical exploration, or other diagnostic methods to gather information about the location and extent of medical conditions.

In summary, medical topography is a detailed mapping and description of the location and position of anatomical structures or pathological changes in the body.

AIDS-related opportunistic infections (AROIs) are infections that occur more frequently or are more severe in people with weakened immune systems, such as those with advanced HIV infection or AIDS. These infections take advantage of a weakened immune system and can affect various organs and systems in the body.

Common examples of AROIs include:

1. Pneumocystis pneumonia (PCP), caused by the fungus Pneumocystis jirovecii
2. Mycobacterium avium complex (MAC) infection, caused by a type of bacteria called mycobacteria
3. Candidiasis, a fungal infection that can affect various parts of the body, including the mouth, esophagus, and genitals
4. Toxoplasmosis, caused by the parasite Toxoplasma gondii
5. Cryptococcosis, a fungal infection that affects the lungs and central nervous system
6. Cytomegalovirus (CMV) infection, caused by a type of herpes virus
7. Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis
8. Cryptosporidiosis, a parasitic infection that affects the intestines
9. Progressive multifocal leukoencephalopathy (PML), a viral infection that affects the brain

Preventing and treating AROIs is an important part of managing HIV/AIDS, as they can cause significant illness and even death in people with weakened immune systems. Antiretroviral therapy (ART) is used to treat HIV infection and prevent the progression of HIV to AIDS, which can help reduce the risk of opportunistic infections. In addition, medications to prevent specific opportunistic infections may be prescribed for people with advanced HIV or AIDS.

Eyelid diseases refer to a variety of medical conditions that affect the function and/or appearance of the eyelids. These can include structural abnormalities, such as entropion (inward turning of the eyelid) or ectropion (outward turning of the eyelid), as well as functional issues like ptosis (drooping of the upper eyelid). Other common eyelid diseases include blepharitis (inflammation of the eyelid margin), chalazion (a blocked oil gland in the eyelid), and cancerous or benign growths on the eyelid. Symptoms of eyelid diseases can vary widely, but often include redness, swelling, pain, itching, tearing, and sensitivity to light. Treatment for these conditions depends on the specific diagnosis and may range from self-care measures and medications to surgical intervention.

Chagas disease, also known as American trypanosomiasis, is a tropical parasitic disease caused by the protozoan *Trypanosoma cruzi*. It is primarily transmitted to humans through the feces of triatomine bugs (also called "kissing bugs"), which defecate on the skin of people while they are sleeping. The disease can also be spread through contaminated food or drink, during blood transfusions, from mother to baby during pregnancy or childbirth, and through organ transplantation.

The acute phase of Chagas disease can cause symptoms such as fever, fatigue, body aches, headache, rash, loss of appetite, diarrhea, and vomiting. However, many people do not experience any symptoms during the acute phase. After several weeks or months, most people enter the chronic phase of the disease, which can last for decades or even a lifetime. During this phase, many people do not have any symptoms, but about 20-30% of infected individuals will develop serious cardiac or digestive complications, such as heart failure, arrhythmias, or difficulty swallowing.

Chagas disease is primarily found in Latin America, where it is estimated that around 6-7 million people are infected with the parasite. However, due to increased travel and migration, cases of Chagas disease have been reported in other parts of the world, including North America, Europe, and Asia. There is no vaccine for Chagas disease, but medications are available to treat the infection during the acute phase and to manage symptoms during the chronic phase.

I'm sorry for any confusion, but the abbreviation "USSR" stands for the Union of Soviet Socialist Republics, which was a socialist state in Eastern Europe and northern and central Asia that existed from 1922 until its dissolution in 1991. It was not a medical term or concept. If you have any questions related to medicine, I would be happy to try to help answer them for you.

Aminoquinolines are a class of drugs that contain a quinoline chemical structure and an amino group. They are primarily used as antimalarial agents, with the most well-known members of this class being chloroquine and hydroxychloroquine. These drugs work by inhibiting the parasite's ability to digest hemoglobin in the red blood cells, which is necessary for its survival and reproduction.

In addition to their antimalarial properties, aminoquinolines have also been studied for their potential anti-inflammatory and immunomodulatory effects. They have been investigated as a treatment for various autoimmune diseases, such as rheumatoid arthritis and lupus, although their use in these conditions is not yet widely accepted.

It's important to note that aminoquinolines can have significant side effects, including gastrointestinal symptoms, retinopathy, and cardiac toxicity. They should only be used under the close supervision of a healthcare provider, and their use may be contraindicated in certain populations, such as pregnant women or individuals with preexisting heart conditions.

I'm sorry for any confusion, but "Mediterranean Region" is not a term with a specific medical definition. The Mediterranean Region typically refers to the geographical area surrounding the Mediterranean Sea, including countries in Southern Europe, North Africa, and Western Asia. However, in a medical context, it might refer to the study of diseases or health characteristics typical of certain populations in this region. For example, the "Mediterranean diet" is a popular term in nutrition and medicine, referring to the traditional eating habits in Mediterranean countries, which are associated with numerous health benefits. If you're looking for medical information related to a specific aspect of the Mediterranean Region or its population, please provide more context so I can give you a more accurate response.

I'm sorry for any confusion, but "French Guiana" is not a medical term or concept. It's a geographical location, specifically an overseas department and region of France, located on the northeastern coast of South America. If you have any questions about geographical places, I'd be happy to try to help answer those, but for medical inquiries, please provide a medical term or concept and I will do my best to provide a definition or explanation.

Trypanosomiasis is a parasitic disease caused by various species of the protozoan genus Trypanosoma. It is transmitted through the bite of an infected tsetse fly (in African trypanosomiasis or sleeping sickness) or reduviid bug (in American trypanosomiasis or Chagas disease). The parasites enter the bloodstream and lymphatic system, causing symptoms such as fever, swollen lymph nodes, skin lesions, and muscle pain. Untreated, it can lead to severe neurological complications and death in both forms of the disease. Prevention measures include avoiding insect bites, using insect repellents, and sleeping under insecticide-treated bed nets.

Rhinophyma is a benign (noncancerous) growth of the skin on and around the nose, which is a late stage manifestation of severe rosacea, a chronic skin condition. It primarily affects middle-aged to older men, more so than women. The nose becomes enlarged, bulbous, and irregular in shape due to thickening of the skin, oil glands (sebaceous glands), and formation of visible blood vessels. The surface may have redness, pustules, and prominent pores. It can cause social embarrassment and psychological distress. Treatment usually involves dermabrasion, laser surgery, or electrosurgery to remove excess tissue and improve the appearance of the nose.

Interleukin-4 (IL-4) is a type of cytokine, which is a cell signaling molecule that mediates communication between cells in the immune system. Specifically, IL-4 is produced by activated T cells and mast cells, among other cells, and plays an important role in the differentiation and activation of immune cells called Th2 cells.

Th2 cells are involved in the immune response to parasites, as well as in allergic reactions. IL-4 also promotes the growth and survival of B cells, which produce antibodies, and helps to regulate the production of certain types of antibodies. In addition, IL-4 has anti-inflammatory effects and can help to downregulate the immune response in some contexts.

Defects in IL-4 signaling have been implicated in a number of diseases, including asthma, allergies, and certain types of cancer.

Host-parasite interactions refer to the relationship between a parasitic organism (the parasite) and its host, which can be an animal, plant, or human body. The parasite lives on or inside the host and derives nutrients from it, often causing harm in the process. This interaction can range from relatively benign to severe, depending on various factors such as the species of the parasite, the immune response of the host, and the duration of infection.

The host-parasite relationship is often categorized based on the degree of harm caused to the host. Parasites that cause little to no harm are called commensals, while those that cause significant damage or disease are called parasitic pathogens. Some parasites can even manipulate their hosts' behavior and physiology to enhance their own survival and reproduction, leading to complex interactions between the two organisms.

Understanding host-parasite interactions is crucial for developing effective strategies to prevent and treat parasitic infections, as well as for understanding the ecological relationships between different species in natural ecosystems.

I'm sorry for any confusion, but "Morocco" is not a medical term. It is the constitutional monarchy with a parliamentary national unity government located in North Africa. It has a population of over 33 million and an area of 446,550 km2. The capital city is Rabat, and the largest city is Casablanca. Morocco's official languages are Arabic and Berber, with French widely spoken as well.

If you have any medical questions or terms that you would like me to define, please let me know!

Tropical medicine is a branch of medicine that deals with health problems that are prevalent in or unique to tropical and subtropical regions. These regions are typically characterized by hot and humid climates, and often have distinct ecological systems that can contribute to the spread of infectious diseases.

The field of tropical medicine encompasses a wide range of health issues, including:

1. Infectious diseases: Many tropical diseases are caused by infectious agents such as bacteria, viruses, parasites, and fungi. Some of the most common infectious diseases in the tropics include malaria, dengue fever, yellow fever, chikungunya, Zika virus, leishmaniasis, schistosomiasis, and Chagas disease.
2. Neglected tropical diseases (NTDs): A group of chronic infectious diseases that primarily affect poor and marginalized populations in the tropics. NTDs include diseases such as human African trypanosomiasis (sleeping sickness), leprosy, Buruli ulcer, and dracunculiasis (guinea worm disease).
3. Zoonotic diseases: Diseases that are transmitted between animals and humans, often through insect vectors or contaminated food and water. Examples of zoonotic diseases in the tropics include rabies, leptospirosis, and Rift Valley fever.
4. Environmental health issues: The tropical environment can pose unique health challenges, such as exposure to toxic chemicals, heat stress, and poor air quality. Tropical medicine also addresses these environmental health issues.
5. Travel medicine: As global travel increases, there is a growing need for medical professionals who are knowledgeable about the health risks associated with traveling to tropical destinations. Tropical medicine physicians often provide pre-travel consultations and post-travel evaluations for international travelers.

Overall, tropical medicine is an essential field that addresses the unique health challenges faced by populations living in or traveling to tropical and subtropical regions.

Facial dermatoses refer to various skin conditions that affect the face. These can include a wide range of disorders, such as:

1. Acne vulgaris: A common skin condition characterized by the formation of comedones (blackheads and whiteheads) and inflammatory papules, pustules, and nodules. It primarily affects the face, neck, chest, and back.
2. Rosacea: A chronic skin condition that causes redness, flushing, and visible blood vessels on the face, along with bumps or pimples and sometimes eye irritation.
3. Seborrheic dermatitis: A common inflammatory skin disorder that causes a red, itchy, and flaky rash, often on the scalp, face, and eyebrows. It can also affect other oily areas of the body, like the sides of the nose and behind the ears.
4. Atopic dermatitis (eczema): A chronic inflammatory skin condition that causes red, itchy, and scaly patches on the skin. While it can occur anywhere on the body, it frequently affects the face, especially in infants and young children.
5. Psoriasis: An autoimmune disorder that results in thick, scaly, silvery, or red patches on the skin. It can affect any part of the body, including the face.
6. Contact dermatitis: A skin reaction caused by direct contact with an allergen or irritant, resulting in redness, itching, and inflammation. The face can be affected when allergens or irritants come into contact with the skin through cosmetics, skincare products, or other substances.
7. Lupus erythematosus: An autoimmune disorder that can cause a butterfly-shaped rash on the cheeks and nose, along with other symptoms like joint pain, fatigue, and photosensitivity.
8. Perioral dermatitis: A inflammatory skin condition that causes redness, small bumps, and dryness around the mouth, often mistaken for acne. It can also affect the skin around the nose and eyes.
9. Vitiligo: An autoimmune disorder that results in the loss of pigmentation in patches of skin, which can occur on the face and other parts of the body.
10. Tinea faciei: A fungal infection that affects the facial skin, causing red, scaly, or itchy patches. It is also known as ringworm of the face.

These are just a few examples of skin conditions that can affect the face. If you experience any unusual symptoms or changes in your skin, it's essential to consult a dermatologist for proper diagnosis and treatment.

Insecticides are substances or mixtures of substances intended for preventing, destroying, or mitigating any pest, including insects, arachnids, or other related pests. They can be chemical or biological agents that disrupt the growth, development, or behavior of these organisms, leading to their death or incapacitation. Insecticides are widely used in agriculture, public health, and residential settings for pest control. However, they must be used with caution due to potential risks to non-target organisms and the environment.

Delayed hypersensitivity, also known as type IV hypersensitivity, is a type of immune response that takes place several hours to days after exposure to an antigen. It is characterized by the activation of T cells (a type of white blood cell) and the release of various chemical mediators, leading to inflammation and tissue damage. This reaction is typically associated with chronic inflammatory diseases, such as contact dermatitis, granulomatous disorders (e.g. tuberculosis), and certain autoimmune diseases.

The reaction process involves the following steps:

1. Sensitization: The first time an individual is exposed to an antigen, T cells are activated and become sensitized to it. This process can take several days.
2. Memory: Some of the activated T cells differentiate into memory T cells, which remain in the body and are ready to respond quickly if the same antigen is encountered again.
3. Effector phase: Upon subsequent exposure to the antigen, the memory T cells become activated and release cytokines, which recruit other immune cells (e.g. macrophages) to the site of inflammation. These cells cause tissue damage through various mechanisms, such as phagocytosis, degranulation, and the release of reactive oxygen species.
4. Chronic inflammation: The ongoing immune response can lead to chronic inflammation, which may result in tissue destruction and fibrosis (scarring).

Examples of conditions associated with delayed hypersensitivity include:

* Contact dermatitis (e.g. poison ivy, nickel allergy)
* Tuberculosis
* Leprosy
* Sarcoidosis
* Rheumatoid arthritis
* Type 1 diabetes mellitus
* Multiple sclerosis
* Inflammatory bowel disease (e.g. Crohn's disease, ulcerative colitis)

I'm sorry for any confusion, but "travel" is not a term that has a specific medical definition. In general, travel refers to the act of moving or journeying from one place to another, often over long distances. However, in a medical context, it might refer to the recommendation that individuals with certain medical conditions or those who are immunocompromised avoid traveling to areas where they may be at increased risk of exposure to infectious diseases. It's always best to check with a healthcare professional for advice related to specific medical situations and travel.

Parasitic diseases are infections or illnesses caused by parasites, which are organisms that live and feed on host organisms, often causing harm. Parasites can be protozoans (single-celled organisms), helminths (worms), or ectoparasites (ticks, mites, fleas). These diseases can affect various body systems and cause a range of symptoms, depending on the type of parasite and the location of infection. They are typically spread through contaminated food or water, insect vectors, or direct contact with an infected host or contaminated environment. Examples of parasitic diseases include malaria, giardiasis, toxoplasmosis, ascariasis, and leishmaniasis.

Coinfection is a term used in medicine to describe a situation where a person is infected with more than one pathogen (infectious agent) at the same time. This can occur when a person is infected with two or more viruses, bacteria, parasites, or fungi. Coinfections can complicate the diagnosis and treatment of infectious diseases, as the symptoms of each infection can overlap and interact with each other.

Coinfections are common in certain populations, such as people who are immunocompromised, have chronic illnesses, or live in areas with high levels of infectious agents. For example, a person with HIV/AIDS may be more susceptible to coinfections with tuberculosis, hepatitis, or pneumocystis pneumonia. Similarly, a person who has recently undergone an organ transplant may be at risk for coinfections with cytomegalovirus, Epstein-Barr virus, or other opportunistic pathogens.

Coinfections can also occur in people who are otherwise healthy but are exposed to multiple infectious agents at once, such as through travel to areas with high levels of infectious diseases or through close contact with animals that carry infectious agents. For example, a person who travels to a tropical area may be at risk for coinfections with malaria and dengue fever, while a person who works on a farm may be at risk for coinfections with influenza and Q fever.

Effective treatment of coinfections requires accurate diagnosis and appropriate antimicrobial therapy for each pathogen involved. In some cases, treating one infection may help to resolve the other, but in other cases, both infections may need to be treated simultaneously to achieve a cure. Preventing coinfections is an important part of infectious disease control, and can be achieved through measures such as vaccination, use of personal protective equipment, and avoidance of high-risk behaviors.

Cricetinae is a subfamily of rodents that includes hamsters, gerbils, and relatives. These small mammals are characterized by having short limbs, compact bodies, and cheek pouches for storing food. They are native to various parts of the world, particularly in Europe, Asia, and Africa. Some species are popular pets due to their small size, easy care, and friendly nature. In a medical context, understanding the biology and behavior of Cricetinae species can be important for individuals who keep them as pets or for researchers studying their physiology.

Emerging communicable diseases are infections whose incidence has increased in the past two decades or threatens to increase in the near future. These diseases can be caused by new microbial agents, or by previously known agents that have newly acquired the ability to cause disease in humans. They may also result from changes in human demographics, behavior, or travel patterns, or from technological or environmental changes. Examples of emerging communicable diseases include COVID-19, Ebola virus disease, Zika virus infection, and West Nile fever.

Pyrethrins are a group of naturally occurring organic compounds extracted from the flowers of Chrysanthemum cinerariaefolium and Chrysanthemum coccineum. They have been used for centuries as insecticides due to their ability to disrupt the nervous system of insects, leading to paralysis and death. Pyrethrins are composed of six esters, pyrethrin I and II, cinerin I and II, and jasmolin I and II, which have different insecticidal properties but share a similar mode of action. They are commonly used in household insect sprays, pet shampoos, and agricultural applications to control a wide range of pests. However, pyrethrins can be toxic to fish and some beneficial insects, so they must be used with caution.

Cytokines are a broad and diverse category of small signaling proteins that are secreted by various cells, including immune cells, in response to different stimuli. They play crucial roles in regulating the immune response, inflammation, hematopoiesis, and cellular communication.

Cytokines mediate their effects by binding to specific receptors on the surface of target cells, which triggers intracellular signaling pathways that ultimately result in changes in gene expression, cell behavior, and function. Some key functions of cytokines include:

1. Regulating the activation, differentiation, and proliferation of immune cells such as T cells, B cells, natural killer (NK) cells, and macrophages.
2. Coordinating the inflammatory response by recruiting immune cells to sites of infection or tissue damage and modulating their effector functions.
3. Regulating hematopoiesis, the process of blood cell formation in the bone marrow, by controlling the proliferation, differentiation, and survival of hematopoietic stem and progenitor cells.
4. Modulating the development and function of the nervous system, including neuroinflammation, neuroprotection, and neuroregeneration.

Cytokines can be classified into several categories based on their structure, function, or cellular origin. Some common types of cytokines include interleukins (ILs), interferons (IFNs), tumor necrosis factors (TNFs), chemokines, colony-stimulating factors (CSFs), and transforming growth factors (TGFs). Dysregulation of cytokine production and signaling has been implicated in various pathological conditions, such as autoimmune diseases, chronic inflammation, cancer, and neurodegenerative disorders.

I apologize for any confusion, but "Military Personnel" is not a medical term. It refers to individuals who serve in the military forces of a country, including the Army, Navy, Air Force, Marine Corps, and Coast Guard. Medical terms typically refer to specific conditions, diagnoses, treatments, or anatomical features related to healthcare. If you have any questions about medical terminology or concepts, I would be happy to help clarify!

Drug resistance, also known as antimicrobial resistance, is the ability of a microorganism (such as bacteria, viruses, fungi, or parasites) to withstand the effects of a drug that was originally designed to inhibit or kill it. This occurs when the microorganism undergoes genetic changes that allow it to survive in the presence of the drug. As a result, the drug becomes less effective or even completely ineffective at treating infections caused by these resistant organisms.

Drug resistance can develop through various mechanisms, including mutations in the genes responsible for producing the target protein of the drug, alteration of the drug's target site, modification or destruction of the drug by enzymes produced by the microorganism, and active efflux of the drug from the cell.

The emergence and spread of drug-resistant microorganisms pose significant challenges in medical treatment, as they can lead to increased morbidity, mortality, and healthcare costs. The overuse and misuse of antimicrobial agents, as well as poor infection control practices, contribute to the development and dissemination of drug-resistant strains. To address this issue, it is crucial to promote prudent use of antimicrobials, enhance surveillance and monitoring of resistance patterns, invest in research and development of new antimicrobial agents, and strengthen infection prevention and control measures.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Central Asia is a geographical region in Asia that stretches from the Caspian Sea in the west to China in the east, and from Russia in the north to Afghanistan in the south. It includes the former Soviet republics of Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan.

The medical definition of Central Asia may refer to the epidemiology, healthcare systems, or health issues specific to this region. For example, Central Asia has a high prevalence of infectious diseases such as tuberculosis, hepatitis, and HIV/AIDS, due to various factors including poverty, lack of access to healthcare, and mobility of populations. In addition, non-communicable diseases such as cardiovascular disease, cancer, and diabetes are also becoming more prevalent in Central Asia, partly due to lifestyle changes such as unhealthy diets, physical inactivity, and tobacco use.

Overall, the medical definition of Central Asia encompasses the unique health challenges and healthcare systems that exist within this geographical region.

In epidemiology, the incidence of a disease is defined as the number of new cases of that disease within a specific population over a certain period of time. It is typically expressed as a rate, with the number of new cases in the numerator and the size of the population at risk in the denominator. Incidence provides information about the risk of developing a disease during a given time period and can be used to compare disease rates between different populations or to monitor trends in disease occurrence over time.

Allopurinol is a medication used to treat chronic gout and certain types of kidney stones. It works by reducing the production of uric acid in the body, which is the substance that can cause these conditions when it builds up in high levels. Allopurinol is a xanthine oxidase inhibitor, meaning it blocks an enzyme called xanthine oxidase from converting purines into uric acid. By doing this, allopurinol helps to lower the levels of uric acid in the body and prevent the formation of new kidney stones or gout attacks.

It is important to note that allopurinol can have side effects, including rash, stomach upset, and liver or kidney problems. It may also interact with other medications, so it is essential to inform your healthcare provider of any other drugs you are taking before starting allopurinol. Your healthcare provider will determine the appropriate dosage and monitoring schedule based on your individual needs and medical history.

Interleukin-12 (IL-12) is a naturally occurring protein that is primarily produced by activated macrophages and dendritic cells, which are types of immune cells. It plays a crucial role in the regulation of the immune response, particularly in the development of cell-mediated immunity.

IL-12 is composed of two subunits, p35 and p40, which combine to form a heterodimer. This cytokine stimulates the differentiation and activation of naive T cells into Th1 cells, which are important for fighting intracellular pathogens such as viruses and bacteria. IL-12 also enhances the cytotoxic activity of natural killer (NK) cells and CD8+ T cells, which can directly kill infected or malignant cells.

In addition to its role in the immune response, IL-12 has been implicated in the pathogenesis of several autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, and psoriasis. As a result, therapeutic strategies targeting IL-12 or its signaling pathways have been explored as potential treatments for these conditions.

'Life cycle stages' is a term used in the context of public health and medicine to describe the different stages that an organism goes through during its lifetime. This concept is particularly important in the field of epidemiology, where understanding the life cycle stages of infectious agents (such as bacteria, viruses, parasites) can help inform strategies for disease prevention and control.

The life cycle stages of an infectious agent may include various forms such as spores, cysts, trophozoites, schizonts, or vectors, among others, depending on the specific organism. Each stage may have different characteristics, such as resistance to environmental factors, susceptibility to drugs, and ability to transmit infection.

For example, the life cycle stages of the malaria parasite include sporozoites (the infective form transmitted by mosquitoes), merozoites (the form that infects red blood cells), trophozoites (the feeding stage inside red blood cells), schizonts (the replicating stage inside red blood cells), and gametocytes (the sexual stage that can be taken up by mosquitoes to continue the life cycle).

Understanding the life cycle stages of an infectious agent is critical for developing effective interventions, such as vaccines, drugs, or other control measures. For example, targeting a specific life cycle stage with a drug may prevent transmission or reduce the severity of disease. Similarly, designing a vaccine to elicit immunity against a particular life cycle stage may provide protection against infection or disease.

Lepromatous leprosy is a type of leprosy, a chronic infectious disease caused by the bacterium Mycobacterium leprae. In this form of the disease, there is a widespread and diffuse involvement of the skin, mucous membranes, and peripheral nerves. The bacteria multiply slowly and spread to the skin, upper respiratory tract, and peripheral nerves.

In lepromatous leprosy, the immune response is weak, allowing for extensive bacterial multiplication and widespread tissue damage. The skin lesions are typically numerous, pale, and have a smooth surface. Nerve involvement can lead to loss of sensation, muscle weakness, and deformities, particularly in the hands and feet.

Lepromatous leprosy is a more severe form of the disease compared to tuberculoid leprosy, which has a stronger immune response and localized skin lesions. Both forms of the disease are treatable with multidrug therapy (MDT), recommended by the World Health Organization (WHO) for all leprosy patients. Early diagnosis and treatment can prevent disability and reduce transmission.

Emaciation is a state of extreme leanness or thinness, often due to lack of nutrition or disease. It is characterized by significant loss of body fat and muscle mass, resulting in a noticeable decrease in overall body weight. Emaciation can be a serious medical condition that requires immediate attention and treatment. In addition to malnutrition and various diseases, emaciation can also result from substance abuse, eating disorders, or mental health conditions such as depression and anxiety. It is important to consult with a healthcare professional if you are experiencing unexplained weight loss or signs of emaciation.

The ribosomal spacer in DNA refers to the non-coding sequences of DNA that are located between the genes for ribosomal RNA (rRNA). These spacer regions are present in the DNA of organisms that have a nuclear genome, including humans and other animals, plants, and fungi.

In prokaryotic cells, such as bacteria, there are two ribosomal RNA genes, 16S and 23S, separated by a spacer region known as the intergenic spacer (IGS). In eukaryotic cells, there are multiple copies of ribosomal RNA genes arranged in clusters called nucleolar organizer regions (NORs), which are located on the short arms of several acrocentric chromosomes. Each cluster contains hundreds to thousands of copies of the 18S, 5.8S, and 28S rRNA genes, separated by non-transcribed spacer regions known as internal transcribed spacers (ITS) and external transcribed spacers (ETS).

The ribosomal spacer regions in DNA are often used as molecular markers for studying evolutionary relationships among organisms because they evolve more rapidly than the rRNA genes themselves. The sequences of these spacer regions can be compared among different species to infer their phylogenetic relationships and to estimate the time since they diverged from a common ancestor. Additionally, the length and composition of ribosomal spacers can vary between individuals within a species, making them useful for studying genetic diversity and population structure.

The external ear is the visible portion of the ear that resides outside of the head. It consists of two main structures: the pinna or auricle, which is the cartilaginous structure that people commonly refer to as the "ear," and the external auditory canal, which is the tubular passageway that leads to the eardrum (tympanic membrane).

The primary function of the external ear is to collect and direct sound waves into the middle and inner ear, where they can be converted into neural signals and transmitted to the brain for processing. The external ear also helps protect the middle and inner ear from damage by foreign objects and excessive noise.

A granuloma is a small, nodular inflammatory lesion that occurs in various tissues in response to chronic infection, foreign body reaction, or autoimmune conditions. Histologically, it is characterized by the presence of epithelioid macrophages, which are specialized immune cells with enlarged nuclei and abundant cytoplasm, often arranged in a palisading pattern around a central area containing necrotic debris, microorganisms, or foreign material.

Granulomas can be found in various medical conditions such as tuberculosis, sarcoidosis, fungal infections, and certain autoimmune disorders like Crohn's disease. The formation of granulomas is a complex process involving both innate and adaptive immune responses, which aim to contain and eliminate the offending agent while minimizing tissue damage.

Trypanosoma cruzi is a protozoan parasite that causes Chagas disease, also known as American trypanosomiasis. It's transmitted to humans and other mammals through the feces of triatomine bugs, often called "kissing bugs." The parasite can also be spread through contaminated food, drink, or from mother to baby during pregnancy or birth.

The life cycle of Trypanosoma cruzi involves two main forms: the infective metacyclic trypomastigote that is found in the bug's feces and the replicative intracellular amastigote that resides within host cells. The metacyclic trypomastigotes enter the host through mucous membranes or skin lesions, where they invade various types of cells and differentiate into amastigotes. These amastigotes multiply by binary fission and then differentiate back into trypomastigotes, which are released into the bloodstream when the host cell ruptures. The circulating trypomastigotes can then infect other cells or be taken up by another triatomine bug during a blood meal, continuing the life cycle.

Clinical manifestations of Chagas disease range from an acute phase with non-specific symptoms like fever, swelling, and fatigue to a chronic phase characterized by cardiac and gastrointestinal complications, which can develop decades after the initial infection. Early detection and treatment of Chagas disease are crucial for preventing long-term health consequences.

Veterinary medicine is the branch of medical science that deals with the prevention, diagnosis, and treatment of diseases, disorders, and injuries in non-human animals. The profession of veterinary medicine is dedicated to the care, health, and welfare of animals, as well as to the promotion of human health through animal research and public health advancements. Veterinarians employ a variety of diagnostic methods including clinical examination, radiography, laboratory testing, and ultrasound imaging. They use a range of treatments, including medication, surgery, and dietary management. In addition, veterinarians may also advise on preventative healthcare measures such as vaccination schedules and parasite control programs.

Parasitic skin diseases are conditions caused by parasites living on or in the skin. These parasites can be insects, mites, or fungi that feed off of the host for their own survival. They can cause a variety of symptoms including itching, rashes, blisters, and lesions on the skin. Examples of parasitic skin diseases include scabies, lice infestations, and ringworm. Treatment typically involves the use of topical or oral medications to kill the parasites and alleviate symptoms.

Liposomes are artificially prepared, small, spherical vesicles composed of one or more lipid bilayers that enclose an aqueous compartment. They can encapsulate both hydrophilic and hydrophobic drugs, making them useful for drug delivery applications in the medical field. The lipid bilayer structure of liposomes is similar to that of biological membranes, which allows them to merge with and deliver their contents into cells. This property makes liposomes a valuable tool in delivering drugs directly to targeted sites within the body, improving drug efficacy while minimizing side effects.

"Eastern Africa" is a geographical term used to describe the eastern portion of the African continent. The United Nations defines Eastern Africa as consisting of the following countries: Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Réunion, Rwanda, Seychelles, Somalia, South Sudan, Tanzania, Uganda, Zambia, and Zimbabwe.

In a medical context, "Eastern Africa" may be used to describe the epidemiology, distribution, or prevalence of various diseases or health conditions in this region. However, it is important to note that there can be significant variation in health outcomes and healthcare systems within Eastern Africa due to factors such as socioeconomic status, infrastructure, and cultural practices. Therefore, any medical definition of "Eastern Africa" should be used with caution and may require further qualification or specification depending on the context.

Bone marrow is the spongy tissue found inside certain bones in the body, such as the hips, thighs, and vertebrae. It is responsible for producing blood-forming cells, including red blood cells, white blood cells, and platelets. There are two types of bone marrow: red marrow, which is involved in blood cell production, and yellow marrow, which contains fatty tissue.

Red bone marrow contains hematopoietic stem cells, which can differentiate into various types of blood cells. These stem cells continuously divide and mature to produce new blood cells that are released into the circulation. Red blood cells carry oxygen throughout the body, white blood cells help fight infections, and platelets play a crucial role in blood clotting.

Bone marrow also serves as a site for immune cell development and maturation. It contains various types of immune cells, such as lymphocytes, macrophages, and dendritic cells, which help protect the body against infections and diseases.

Abnormalities in bone marrow function can lead to several medical conditions, including anemia, leukopenia, thrombocytopenia, and various types of cancer, such as leukemia and multiple myeloma. Bone marrow aspiration and biopsy are common diagnostic procedures used to evaluate bone marrow health and function.

A rural population refers to people who live in areas that are outside of urban areas, typically defined as having fewer than 2,000 residents and lacking certain infrastructure and services such as running water, sewage systems, and paved roads. Rural populations often have less access to healthcare services, education, and economic opportunities compared to their urban counterparts. This population group can face unique health challenges, including higher rates of poverty, limited access to specialized medical care, and a greater exposure to environmental hazards such as agricultural chemicals and industrial pollutants.

A biopsy is a medical procedure in which a small sample of tissue is taken from the body to be examined under a microscope for the presence of disease. This can help doctors diagnose and monitor various medical conditions, such as cancer, infections, or autoimmune disorders. The type of biopsy performed will depend on the location and nature of the suspected condition. Some common types of biopsies include:

1. Incisional biopsy: In this procedure, a surgeon removes a piece of tissue from an abnormal area using a scalpel or other surgical instrument. This type of biopsy is often used when the lesion is too large to be removed entirely during the initial biopsy.

2. Excisional biopsy: An excisional biopsy involves removing the entire abnormal area, along with a margin of healthy tissue surrounding it. This technique is typically employed for smaller lesions or when cancer is suspected.

3. Needle biopsy: A needle biopsy uses a thin, hollow needle to extract cells or fluid from the body. There are two main types of needle biopsies: fine-needle aspiration (FNA) and core needle biopsy. FNA extracts loose cells, while a core needle biopsy removes a small piece of tissue.

4. Punch biopsy: In a punch biopsy, a round, sharp tool is used to remove a small cylindrical sample of skin tissue. This type of biopsy is often used for evaluating rashes or other skin abnormalities.

5. Shave biopsy: During a shave biopsy, a thin slice of tissue is removed from the surface of the skin using a sharp razor-like instrument. This technique is typically used for superficial lesions or growths on the skin.

After the biopsy sample has been collected, it is sent to a laboratory where a pathologist will examine the tissue under a microscope and provide a diagnosis based on their findings. The results of the biopsy can help guide further treatment decisions and determine the best course of action for managing the patient's condition.

Lymph nodes are small, bean-shaped organs that are part of the immune system. They are found throughout the body, especially in the neck, armpits, groin, and abdomen. Lymph nodes filter lymph fluid, which carries waste and unwanted substances such as bacteria, viruses, and cancer cells. They contain white blood cells called lymphocytes that help fight infections and diseases by attacking and destroying the harmful substances found in the lymph fluid. When an infection or disease is present, lymph nodes may swell due to the increased number of immune cells and fluid accumulation as they work to fight off the invaders.

Cellular immunity, also known as cell-mediated immunity, is a type of immune response that involves the activation of immune cells, such as T lymphocytes (T cells), to protect the body against infected or damaged cells. This form of immunity is important for fighting off infections caused by viruses and intracellular bacteria, as well as for recognizing and destroying cancer cells.

Cellular immunity involves a complex series of interactions between various immune cells and molecules. When a pathogen infects a cell, the infected cell displays pieces of the pathogen on its surface in a process called antigen presentation. This attracts T cells, which recognize the antigens and become activated. Activated T cells then release cytokines, chemicals that help coordinate the immune response, and can directly attack and kill infected cells or help activate other immune cells to do so.

Cellular immunity is an important component of the adaptive immune system, which is able to learn and remember specific pathogens in order to mount a faster and more effective response upon subsequent exposure. This form of immunity is also critical for the rejection of transplanted organs, as the immune system recognizes the transplanted tissue as foreign and attacks it.

Perissodactyla is not a medical term, but rather a taxonomic order in zoology. It includes mammals with an odd number of toes on each foot and a particular type of digestive system called "hindgut fermentation." The order Perissodactyla includes horses, rhinos, and tapirs.

Parasitic liver diseases refer to conditions caused by protozoa or helminths (parasitic worms) that infect and damage the liver. These parasites can enter the body through contaminated food, water, or direct contact with an infected host. Some examples of parasitic liver diseases include:

1. Ascariasis: Caused by the roundworm Ascaris lumbricoides, which can infect the liver and bile ducts, leading to inflammation, obstruction, and abscess formation.
2. Echinococcosis (Hydatid disease): A rare but serious condition caused by the larval stage of tapeworms from the genus Echinococcus. The liver is the most commonly affected organ, with cysts forming in the liver parenchyma that can grow slowly over several years and cause complications such as rupture or secondary bacterial infection.
3. Fascioliasis: A foodborne trematode (fluke) infection caused by Fasciola hepatica or Fasciola gigantica, which affects the liver and bile ducts. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
4. Leishmaniasis: A protozoan infection caused by Leishmania spp., which can affect various organs, including the liver. Visceral leishmaniasis (kala-azar) is the most severe form of the disease, characterized by hepatosplenomegaly, fever, and anemia.
5. Toxoplasmosis: A protozoan infection caused by Toxoplasma gondii, which can affect the liver and other organs. While most immunocompetent individuals remain asymptomatic or experience mild flu-like symptoms, immunocompromised patients are at risk of severe liver damage and disseminated disease.
6. Schistosomiasis: A trematode (fluke) infection caused by Schistosoma spp., which affects the liver and portal venous system. The parasites lay eggs in the liver, causing granulomatous inflammation, fibrosis, and portal hypertension.
7. Fasciolopsiasis: A trematode (fluke) infection caused by Fasciolopsis buski, which affects the small intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
8. Paragonimiasis: A trematode (lung fluke) infection caused by Paragonimus spp., which can affect the lungs, brain, and other organs, including the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
9. Clonorchiasis: A trematode (liver fluke) infection caused by Clonorchis sinensis, which affects the bile ducts and liver. The parasites lay eggs in the bile ducts, causing inflammation, cholangitis, and cholangiocarcinoma.
10. Opisthorchiasis: A trematode (liver fluke) infection caused by Opisthorchis spp., which affects the bile ducts and liver. The parasites lay eggs in the bile ducts, causing inflammation, cholangitis, and cholangiocarcinoma.
11. Heterophyiasis: A trematode (intestinal fluke) infection caused by Heterophyes spp., which affects the small intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
12. Metagonimiasis: A trematode (intestinal fluke) infection caused by Metagonimus spp., which affects the small intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
13. Echinostomiasis: A trematode (intestinal fluke) infection caused by Echinostoma spp., which affects the small intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
14. Gastrodiscoidiasis: A trematode (intestinal fluke) infection caused by Gastrodiscoides spp., which affects the large intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
15. Fascioliasis: A trematode (liver fluke) infection caused by Fasciola spp., which affects the liver and bile ducts. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
16. Paragonimiasis: A trematode (lung fluke) infection caused by Paragonimus spp., which affects the lungs and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
17. Schistosomiasis: A trematode (blood fluke) infection caused by Schistosoma spp., which affects the blood vessels and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
18. Clonorchiasis: A trematode (liver fluke) infection caused by Clonorchis sinensis, which affects the liver and bile ducts. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
19. Opisthorchiasis: A trematode (liver fluke) infection caused by Opisthorchis spp., which affects the liver and bile ducts. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
20. Metagonimiasis: A trematode (intestinal fluke) infection caused by Metagonimus spp., which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
21. Heterophyesiasis: A trematode (intestinal fluke) infection caused by Heterophyes spp., which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
22. Echinostomiasis: A trematode (intestinal fluke) infection caused by Echinostoma spp., which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
23. Fasciolopsiasis: A trematode (intestinal fluke) infection caused by Fasciolopsis buski, which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
24. Paragonimiasis: A trematode (lung fluke) infection caused by Paragonimus spp., which affects the lungs and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
25. Spirometra mansoni: A trematode (tapeworm) infection caused by Spirometra mansoni, which affects the brain and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
26. Taenia solium: A trematode (tapeworm) infection caused by Taenia solium, which affects the brain and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
27. Hymenolepis nana: A trematode (tapeworm) infection caused by Hymenolepis nana, which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
28. Diphyllobothrium latum: A trematode (tapeworm) infection caused by Diphyllobothrium latum, which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
29. Echinococcus granulosus:

I'm sorry for any confusion, but "Sri Lanka" is not a medical term or concept. Sri Lanka is an island country located in the Indian Ocean, south of India. It is known for its diverse landscapes ranging from rainforests and arid plains to highlands and sandy beaches.

If you have any questions related to medicine or healthcare, I would be happy to try and help answer them!

Seroepidemiologic studies are a type of epidemiological study that measures the presence and levels of antibodies in a population's blood serum to investigate the prevalence, distribution, and transmission of infectious diseases. These studies help to identify patterns of infection and immunity within a population, which can inform public health policies and interventions.

Seroepidemiologic studies typically involve collecting blood samples from a representative sample of individuals in a population and testing them for the presence of antibodies against specific pathogens. The results are then analyzed to estimate the prevalence of infection and immunity within the population, as well as any factors associated with increased or decreased risk of infection.

These studies can provide valuable insights into the spread of infectious diseases, including emerging and re-emerging infections, and help to monitor the effectiveness of vaccination programs. Additionally, seroepidemiologic studies can also be used to investigate the transmission dynamics of infectious agents, such as identifying sources of infection or tracking the spread of antibiotic resistance.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Climate, in the context of environmental science and medicine, refers to the long-term average of weather conditions (such as temperature, humidity, atmospheric pressure, wind, rainfall, and other meteorological elements) in a given region over a period of years to decades. It is the statistical description of the weather patterns that occur in a particular location over long periods of time.

In medical terms, climate can have significant impacts on human health, both physical and mental. For example, extreme temperatures, air pollution, and ultraviolet radiation levels associated with certain climates can increase the risk of respiratory and cardiovascular diseases, heat-related illnesses, and skin cancer. Similarly, changes in climate patterns can affect the distribution and prevalence of infectious diseases, such as malaria and Lyme disease.

Climate change, which refers to significant long-term changes in the statistical distribution of weather patterns over periods ranging from decades to millions of years, can have even more profound impacts on human health, including increased rates of heat-related illnesses and deaths, worsening air quality, and altered transmission patterns of infectious diseases.

Disease susceptibility, also known as genetic predisposition or genetic susceptibility, refers to the increased likelihood or risk of developing a particular disease due to inheriting specific genetic variations or mutations. These genetic factors can make an individual more vulnerable to certain diseases compared to those who do not have these genetic changes.

It is important to note that having a genetic predisposition does not guarantee that a person will definitely develop the disease. Other factors, such as environmental exposures, lifestyle choices, and additional genetic variations, can influence whether or not the disease will manifest. In some cases, early detection and intervention may help reduce the risk or delay the onset of the disease in individuals with a known genetic susceptibility.

'Azure stains' is a term used in pathology to describe a histological staining technique that uses a type of dye called methyl blue, which turns the stained structures a blue-purple color. This technique is often used to stain acid mucins, which are found in various types of tissues and can be indicative of certain medical conditions.

In particular, azure stains are sometimes used to help diagnose certain types of cancer, such as mucoepidermoid carcinoma, a type of salivary gland tumor that produces acid mucins. The staining technique can help pathologists identify the presence and distribution of these mucins within the tumor cells, which can aid in making an accurate diagnosis and determining the best course of treatment.

It's worth noting that there are several different types of histological stains that use various dyes to highlight different structures or features within tissues. Azure stains are just one example of these techniques, and they are typically used in conjunction with other staining methods to provide a comprehensive picture of the tissue being examined.

I'm sorry for any confusion, but there seems to be a mistake in your question. "Leishmaniavirus" is not a term used in medical literature or recognized as a medical condition. Leishmania, however, refers to a genus of protozoan parasites that can cause a group of diseases known as leishmaniasis in humans and animals. If you have any questions about Leishmania or leishmaniasis, I would be happy to help clarify those for you.

Species specificity is a term used in the field of biology, including medicine, to refer to the characteristic of a biological entity (such as a virus, bacterium, or other microorganism) that allows it to interact exclusively or preferentially with a particular species. This means that the biological entity has a strong affinity for, or is only able to infect, a specific host species.

For example, HIV is specifically adapted to infect human cells and does not typically infect other animal species. Similarly, some bacterial toxins are species-specific and can only affect certain types of animals or humans. This concept is important in understanding the transmission dynamics and host range of various pathogens, as well as in developing targeted therapies and vaccines.

Trifluralin is a selective, pre-emergence herbicide that is primarily used to control annual grasses and broadleaf weeds in various crops such as corn, soybeans, vegetables, fruits, and ornamentals. It works by inhibiting the germination of weed seeds and preventing their growth by disrupting the cell division process. Trifluralin is a dinitroaniline compound and its chemical formula is C12H16F3N3O4.

In a medical context, trifluralin may be relevant in cases of accidental or intentional ingestion, inhalation, or skin contact, which can result in toxicity or other adverse health effects. Symptoms of trifluralin exposure may include irritation of the eyes, skin, and respiratory tract, nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, tremors, and seizures. Chronic exposure to trifluralin has been linked to reproductive and developmental toxicity in animals, but its effects on human health are not well-studied.

It is important for healthcare professionals to be aware of the potential health hazards associated with trifluralin exposure and to take appropriate measures to protect themselves and their patients. This may include using personal protective equipment (PPE) when handling trifluralin, providing proper ventilation in areas where it is used or stored, and seeking medical attention promptly in cases of suspected exposure.

Mononuclear leukocytes are a type of white blood cells (leukocytes) that have a single, large nucleus. They include lymphocytes (B-cells, T-cells, and natural killer cells), monocytes, and dendritic cells. These cells play important roles in the body's immune system, including defending against infection and disease, and participating in immune responses and surveillance. Mononuclear leukocytes can be found in the bloodstream as well as in tissues throughout the body. They are involved in both innate and adaptive immunity, providing specific and nonspecific defense mechanisms to protect the body from harmful pathogens and other threats.

I'm sorry for any confusion, but "Urban Population" is not a medical term. It is a demographic term used to describe the portion of a country's population that lives in areas classified as urban. The United Nations defines an urban area as a city, town, or other agglomeration with a population of 20,000 or more. However, the specific definition can vary by country and organization.

In contrast, medical terms typically refer to conditions, diseases, symptoms, treatments, or healthcare-related concepts. If you have any questions related to health or medicine, I'd be happy to help if I can!

Salivary proteins and peptides refer to the diverse group of molecules that are present in saliva, which is the clear, slightly alkaline fluid produced by the salivary glands in the mouth. These proteins and peptides play a crucial role in maintaining oral health and contributing to various physiological functions.

Some common types of salivary proteins and peptides include:

1. **Mucins**: These are large, heavily glycosylated proteins that give saliva its viscous quality. They help to lubricate the oral cavity, protect the mucosal surfaces, and aid in food bolus formation.
2. **Amylases**: These enzymes break down carbohydrates into simpler sugars, initiating the digestive process even before food reaches the stomach.
3. **Proline-rich proteins (PRPs)**: PRPs contribute to the buffering capacity of saliva and help protect against tooth erosion by forming a protective layer on tooth enamel.
4. **Histatins**: These are small cationic peptides with antimicrobial properties, playing a significant role in maintaining oral microbial homeostasis and preventing dental caries.
5. **Lactoferrin**: An iron-binding protein that exhibits antibacterial, antifungal, and anti-inflammatory activities, contributing to the overall oral health.
6. **Statherin and Cystatins**: These proteins regulate calcium phosphate precipitation, preventing dental calculus formation and maintaining tooth mineral homeostasis.

Salivary proteins and peptides have attracted significant interest in recent years due to their potential diagnostic and therapeutic applications. Alterations in the composition of these molecules can provide valuable insights into various oral and systemic diseases, making them promising biomarkers for disease detection and monitoring.

Reagent strips, also known as diagnostic or test strips, are narrow pieces of plastic material that have been impregnated with chemical reagents. They are used in the qualitative or semi-quantitative detection of various substances, such as glucose, proteins, ketones, blood, and white blood cells, in body fluids like urine or blood.

Reagent strips typically contain multiple pad areas, each with a different reagent that reacts to a specific substance. To perform the test, a small amount of the fluid is applied to the strip, and the reaction between the reagents and the target substance produces a visible color change. The resulting color can then be compared to a standardized color chart to determine the concentration or presence of the substance.

Reagent strips are widely used in point-of-care testing, providing quick and convenient results for healthcare professionals and patients alike. They are commonly used for monitoring conditions such as diabetes (urine or blood glucose levels), urinary tract infections (leukocytes and nitrites), and kidney function (protein and blood).

I'm sorry for any confusion, but "Geographic Information Systems" (GIS) is not a medical term. GIS is a system designed to capture, store, manipulate, analyze, manage, and present all types of geographical data. It can be used in various fields, including public health and epidemiology, to map and analyze the spread of diseases, identify environmental risk factors, plan health services delivery, and inform evidence-based decision making.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

Combination drug therapy is a treatment approach that involves the use of multiple medications with different mechanisms of action to achieve better therapeutic outcomes. This approach is often used in the management of complex medical conditions such as cancer, HIV/AIDS, and cardiovascular diseases. The goal of combination drug therapy is to improve efficacy, reduce the risk of drug resistance, decrease the likelihood of adverse effects, and enhance the overall quality of life for patients.

In combining drugs, healthcare providers aim to target various pathways involved in the disease process, which may help to:

1. Increase the effectiveness of treatment by attacking the disease from multiple angles.
2. Decrease the dosage of individual medications, reducing the risk and severity of side effects.
3. Slow down or prevent the development of drug resistance, a common problem in chronic diseases like HIV/AIDS and cancer.
4. Improve patient compliance by simplifying dosing schedules and reducing pill burden.

Examples of combination drug therapy include:

1. Antiretroviral therapy (ART) for HIV treatment, which typically involves three or more drugs from different classes to suppress viral replication and prevent the development of drug resistance.
2. Chemotherapy regimens for cancer treatment, where multiple cytotoxic agents are used to target various stages of the cell cycle and reduce the likelihood of tumor cells developing resistance.
3. Cardiovascular disease management, which may involve combining medications such as angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, and statins to control blood pressure, heart rate, fluid balance, and cholesterol levels.
4. Treatment of tuberculosis, which often involves a combination of several antibiotics to target different aspects of the bacterial life cycle and prevent the development of drug-resistant strains.

When prescribing combination drug therapy, healthcare providers must carefully consider factors such as potential drug interactions, dosing schedules, adverse effects, and contraindications to ensure safe and effective treatment. Regular monitoring of patients is essential to assess treatment response, manage side effects, and adjust the treatment plan as needed.

Antimony potassium tartrate is an inorganic compound with the chemical formula KSbC4H4O7. It is a white crystalline solid that is soluble in water and has been used historically in medical treatments, most notably in the treatment of leishmaniasis, a parasitic disease. However, due to its potential toxicity and the availability of safer alternatives, it is no longer commonly used in modern medicine.

I'm sorry for any confusion, but "geography" is not a term that has a medical definition. Geography is a field of study that deals with the location and distribution of physical and cultural features on Earth's surface, as well as how humans interact with and affect those features. It is not a concept that is typically used in a medical context. If you have any questions related to medicine or healthcare, I would be happy to try to help answer them for you!

Topical administration refers to a route of administering a medication or treatment directly to a specific area of the body, such as the skin, mucous membranes, or eyes. This method allows the drug to be applied directly to the site where it is needed, which can increase its effectiveness and reduce potential side effects compared to systemic administration (taking the medication by mouth or injecting it into a vein or muscle).

Topical medications come in various forms, including creams, ointments, gels, lotions, solutions, sprays, and patches. They may be used to treat localized conditions such as skin infections, rashes, inflammation, or pain, or to deliver medication to the eyes or mucous membranes for local or systemic effects.

When applying topical medications, it is important to follow the instructions carefully to ensure proper absorption and avoid irritation or other adverse reactions. This may include cleaning the area before application, covering the treated area with a dressing, or avoiding exposure to sunlight or water after application, depending on the specific medication and its intended use.

Recombinant proteins are artificially created proteins produced through the use of recombinant DNA technology. This process involves combining DNA molecules from different sources to create a new set of genes that encode for a specific protein. The resulting recombinant protein can then be expressed, purified, and used for various applications in research, medicine, and industry.

Recombinant proteins are widely used in biomedical research to study protein function, structure, and interactions. They are also used in the development of diagnostic tests, vaccines, and therapeutic drugs. For example, recombinant insulin is a common treatment for diabetes, while recombinant human growth hormone is used to treat growth disorders.

The production of recombinant proteins typically involves the use of host cells, such as bacteria, yeast, or mammalian cells, which are engineered to express the desired protein. The host cells are transformed with a plasmid vector containing the gene of interest, along with regulatory elements that control its expression. Once the host cells are cultured and the protein is expressed, it can be purified using various chromatography techniques.

Overall, recombinant proteins have revolutionized many areas of biology and medicine, enabling researchers to study and manipulate proteins in ways that were previously impossible.

T-lymphocytes, also known as T-cells, are a type of white blood cell that plays a key role in the adaptive immune system's response to infection. They are produced in the bone marrow and mature in the thymus gland. There are several different types of T-cells, including CD4+ helper T-cells, CD8+ cytotoxic T-cells, and regulatory T-cells (Tregs).

CD4+ helper T-cells assist in activating other immune cells, such as B-lymphocytes and macrophages. They also produce cytokines, which are signaling molecules that help coordinate the immune response. CD8+ cytotoxic T-cells directly kill infected cells by releasing toxic substances. Regulatory T-cells help maintain immune tolerance and prevent autoimmune diseases by suppressing the activity of other immune cells.

T-lymphocytes are important in the immune response to viral infections, cancer, and other diseases. Dysfunction or depletion of T-cells can lead to immunodeficiency and increased susceptibility to infections. On the other hand, an overactive T-cell response can contribute to autoimmune diseases and chronic inflammation.

Arginase is an enzyme that plays a role in the metabolism of arginine, an amino acid. It works by breaking down arginine into ornithine and urea. This reaction is part of the urea cycle, which helps to rid the body of excess nitrogen waste produced during the metabolism of proteins. Arginase is found in various tissues throughout the body, including the liver, where it plays a key role in the detoxification of ammonia.

Antiparasitic agents are a type of medication used to treat parasitic infections. These agents include a wide range of drugs that work to destroy, inhibit the growth of, or otherwise eliminate parasites from the body. Parasites are organisms that live on or inside a host and derive nutrients at the host's expense.

Antiparasitic agents can be divided into several categories based on the type of parasite they target. Some examples include:

* Antimalarial agents: These drugs are used to treat and prevent malaria, which is caused by a parasite that is transmitted through the bites of infected mosquitoes.
* Antiprotozoal agents: These drugs are used to treat infections caused by protozoa, which are single-celled organisms that can cause diseases such as giardiasis, amoebic dysentery, and sleeping sickness.
* Antihelminthic agents: These drugs are used to treat infections caused by helminths, which are parasitic worms that can infect various organs of the body, including the intestines, lungs, and skin. Examples include roundworms, tapeworms, and flukes.

Antiparasitic agents work in different ways to target parasites. Some disrupt the parasite's metabolism or interfere with its ability to reproduce. Others damage the parasite's membrane or exoskeleton, leading to its death. The specific mechanism of action depends on the type of antiparasitic agent and the parasite it is targeting.

It is important to note that while antiparasitic agents can be effective in treating parasitic infections, they can also have side effects and potential risks. Therefore, it is essential to consult with a healthcare provider before starting any antiparasitic medication to ensure safe and appropriate use.

A disease outbreak is defined as the occurrence of cases of a disease in excess of what would normally be expected in a given time and place. It may affect a small and localized group or a large number of people spread over a wide area, even internationally. An outbreak may be caused by a new agent, a change in the agent's virulence or host susceptibility, or an increase in the size or density of the host population.

Outbreaks can have significant public health and economic impacts, and require prompt investigation and control measures to prevent further spread of the disease. The investigation typically involves identifying the source of the outbreak, determining the mode of transmission, and implementing measures to interrupt the chain of infection. This may include vaccination, isolation or quarantine, and education of the public about the risks and prevention strategies.

Examples of disease outbreaks include foodborne illnesses linked to contaminated food or water, respiratory infections spread through coughing and sneezing, and mosquito-borne diseases such as Zika virus and West Nile virus. Outbreaks can also occur in healthcare settings, such as hospitals and nursing homes, where vulnerable populations may be at increased risk of infection.

Restriction Fragment Length Polymorphism (RFLP) is a term used in molecular biology and genetics. It refers to the presence of variations in DNA sequences among individuals, which can be detected by restriction enzymes. These enzymes cut DNA at specific sites, creating fragments of different lengths.

In RFLP analysis, DNA is isolated from an individual and treated with a specific restriction enzyme that cuts the DNA at particular recognition sites. The resulting fragments are then separated by size using gel electrophoresis, creating a pattern unique to that individual's DNA. If there are variations in the DNA sequence between individuals, the restriction enzyme may cut the DNA at different sites, leading to differences in the length of the fragments and thus, a different pattern on the gel.

These variations can be used for various purposes, such as identifying individuals, diagnosing genetic diseases, or studying evolutionary relationships between species. However, RFLP analysis has largely been replaced by more modern techniques like polymerase chain reaction (PCR)-based methods and DNA sequencing, which offer higher resolution and throughput.

An immunocompromised host refers to an individual who has a weakened or impaired immune system, making them more susceptible to infections and decreased ability to fight off pathogens. This condition can be congenital (present at birth) or acquired (developed during one's lifetime).

Acquired immunocompromised states may result from various factors such as medical treatments (e.g., chemotherapy, radiation therapy, immunosuppressive drugs), infections (e.g., HIV/AIDS), chronic diseases (e.g., diabetes, malnutrition, liver disease), or aging.

Immunocompromised hosts are at a higher risk for developing severe and life-threatening infections due to their reduced immune response. Therefore, they require special consideration when it comes to prevention, diagnosis, and treatment of infectious diseases.

... post kala-azar dermal leishmaniasis. Brahmachari's cure for visceral leishmaniasis was the urea salt of para-amino-phenyl ... Visceral leishmaniasis (VL), also known as kala-azar (Hindi: kālā āzār, "black sickness") or "black fever", is the most severe ... When people develop visceral leishmaniasis, the most typical symptoms are fever and the enlargement of the spleen, with ... 2007). "Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?" (PDF). Nature Reviews Microbiology. 5 ...
"Visceral Leishmaniasis - WTCCC". www.wtccc.org.uk. Retrieved 2 June 2018. Institute, Telethon Kids (25 May 2015), Professor ... Blackwell discovered that cell-mediated immunity is responsible for the genetic risk of visceral leishmaniasis that allows ... Cox, F. E. G. (1989). "Cell Biology and Immunology of Leishmaniasis". Leishmaniasis. Boston, MA: Springer US. pp. 255-257. doi: ... Hart, D. T. (27 November 2013). Leishmaniasis: The Current Status and New Strategies for Control: Proceedings of the NATO ...
Zijlstra, E E; El-Hassan, A. M. (2001-04). Leishmaniasis in Sudan. 3. Visceral leishmaniasis. Transactions of The Royal Society ... Zijlstra, E. E.; Musa, A. M.; Khalil, E. a. G.; Hassan, IM El; El-Hassan, A. M. (2003-02). Postkala-azar dermal leishmaniasis. ... El Hassan focused on epidemiology and immunopathology of tropical and infectious diseases, especially leishmaniasis and ... a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. The ...
Singh, S. P.; Reddy, D. C. S.; Rai, M.; Sundar, S. (June 2006). "Serious underreporting of visceral leishmaniasis through ... Bora, D (1999). "Epidemiology of visceral leishmaniasis in India". The National Medical Journal of India. 12 (2): 62-8. PMID ... Sundar, S; Singh, OP; Chakravarty, J (November 2018). "Visceral leishmaniasis elimination targets in India, strategies for ... Sundar, S; Chatterjee, M (March 2006). "Visceral leishmaniasis - current therapeutic modalities". The Indian Journal of Medical ...
Some species tend to cause cutaneous leishmaniasis (e.g., L. major and L.tropica), whereas some species tend to cause visceral ... Cutaneous leishmaniasis is the most common form of leishmaniasis affecting humans. It is a skin infection caused by a single- ... Besides humans, cutaneous leishmaniasis often affects other animals, notably in dogs as canine leishmaniasis. Calvopiña M, ... "Leishmaniasis (cutaneous and visceral)" (PDF). Ames, Iowa: College of Veterinary Medicine, Iowa State University. Retrieved ...
den Boer M, Davidson RN (April 2006). "Treatment options for visceral leishmaniasis". Expert Review of Anti-Infective Therapy. ... Amphotericin B is used for life-threatening protozoan infections such as visceral leishmaniasis and primary amoebic ... August 2009). "Highly effective oral amphotericin B formulation against murine visceral leishmaniasis". The Journal of ... World Health Organization (March 2010). Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the ...
"Kala Azar" is visceral leishmaniasis. Adler, S.; Theodor, O. (1931). "Investigations on Mediterranean Kala Azar. I.-- ... Leishmaniasis was a regional problem and it was common to infect Chinese hamsters as a model organism to study the disease. ...
Visceral leishmaniasis, which is the most common in the Northeast region of Brazil, causes the infected to have fever, skin ... Visceral leishmaniasis causes the infected to have a fever, skin lesions, skin tumors, loss in weight, spleen and liver ... Arias, Jorge (June 1996). "The Reemergence of Visceral Leishmaniasis in Brazil". Emerging Infectious Diseases. 2 (2): 145-146. ... "Disseminated Leishmaniasis: A New and Emerging Form of Leishmaniasis Observed in Northeastern Brazil". The Journal of ...
World Health Organisation (2011). Visceral leishmaniasis rapid diagnostic test performance (PDF). ISBN 9789241502238. Retrieved ... "A Global Comparative Evaluation of Commercial Immunochromatographic Rapid Diagnostic Tests for Visceral Leishmaniasis". ... consultant in their RDT evaluation for Leishmaniasis program whilst working at the Koninklijk Instituut voor de Tropen. Tobin, ...
It is a human blood parasite responsible for visceral leishmaniasis or kala-azar, the most severe form of leishmaniasis. It ... at Centers for Disease Control and Prevention Brief account Transmission of visceral leishmaniasis Visceral leishmaniasis at ... This was the first time an oral drug is effective for visceral leishmaniasis. Clinical trials showed that the new drug is ... Mahajan R.C.; Mohan K. (1996). "Epidemiology of visceral leishmaniasis and its control". In M. Ziya Alkan; M. Ali Özcel (eds ...
"Injectable paromomycin for Visceral leishmaniasis in India". The New England Journal of Medicine. 356 (25): 2571-2581. doi: ... and in trials with visceral leishmaniasis in the early 1990s. The route of administration is intramuscular injection and ... and other diseases such as leishmaniasis. Paromomycin was demonstrated to be effective against cutaneous leishmaniasis in ... Paromomycin is an antimicrobial used to treat a number of parasitic infections including amebiasis, giardiasis, leishmaniasis, ...
Nakkazi, E. (March 12, 2012). "New vaccine trials to prevent visceral leishmaniasis". New Science Journalism. Retrieved June 16 ... vaccine Syphilis vaccine Tularemia vaccine Yersinia pestis vaccine Chagas disease vaccine Hookworm vaccine Leishmaniasis ...
"The reemergence of visceral leishmaniasis in Brazil." Emerging infectious diseases vol. 2,2 (1996): 145-6. doi:10.3201/ ... The emergence of leishmaniasis in Brazil, specifically the Northeast state of Ceará, is theorized to date back to the Great ... It is very possible that a portion of those could have died because of Leishmaniasis. An unknown disease is also mentioned by ... Direct and primary evidence of Leishmaniasis' existence is extremely minimal as the disease was not known to the Northeast and ...
This includes the three forms of leishmaniasis: cutaneous, visceral and mucosal. It may be used with liposomal amphotericin B ... Miltefosine is primarily used for the treatment of visceral and New World cutaneous leishmaniasis, and is undergoing clinical ... launches Impavido (miltefosine), the first and only oral Rx treatment for visceral, mucosal and cutaneous leishmaniasis, in the ... July 2014). "Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure". The Journal of Infectious ...
Nakkazi, E. (March 12, 2012). "New vaccine trials to prevent visceral leishmaniasis". New Science Journalism. Retrieved June 16 ...
This includes visceral, mucocutaneous, and cutaneous leishmaniasis. It is given by injection into a muscle or into the area ... Meglumine antimoniate is a medicine used to treat leishmaniasis. ...
Post-kala-azar dermal leishmaniasis (PKDL) is a complication of visceral leishmaniasis (VL); it is characterised by a macular, ... Kala azar (Visceral leishmaniasis) in India refers to the special circumstances of the disease kala azar as it exists in India ... Kala azar, also called visceral leishmaniasis, is a disease in which a parasite migrates to the internal organs such as the ... Cota, Gláucia F.; de Sousa, Marcos R.; Rabello, Ana; Jaffe, Charles L. (7 June 2011). "Predictors of Visceral Leishmaniasis ...
... regulatory T cells in human visceral leishmaniasis Trial of oral miltefosine for visceral leishmaniasis Determinants of ... Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Failure of Pentavalent Antimony in Visceral ... "Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?". Nature Reviews Microbiology. 5 (11): 873-882 ... "Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic". Clinical ...
Kshirsagar, Nilima A. (2014). "Single-dose liposomal amphotericin B for visceral leishmaniasis". The Lancet Global Health. 2 (4 ... "Different liposomal amphotericin B formulations for visceral leishmaniasis-Author's reply". The Lancet Global Health. 2 (8): ...
Her research focuses on understanding the genetics of Visceral leishmaniasis. She was awarded the 2007 Royal Society Pfizer ... and susceptibility to visceral leishmaniasis in The Sudan. European Journal of Human Genetics. 12 (1): 66-74. doi:10.1038/sj. ... Genetics and visceral leishmaniasis: of mice and man. Parasite Immunology. 31 (5): 254-266. doi:10.1111/j.1365-3024.2009.01102. ... Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1. Genes & Immunity. 4 ...
Visceral leishmaniasis § Diagnosis Howanitz and Howanitz, Laboratory Medicine. Published by Church Livingston; 1991: pp 825-828 ...
"Risk Factors for Death in Children with Visceral Leishmaniasis". PLOS Neglected Tropical Diseases. 4 (11): e877. doi:10.1371/ ...
... an outbreak of cutaneous and visceral leishmaniasis was reported from Madrid, Spain, between 2010 and 2012. Leishmaniasis is ... Leishmaniasis at Curlie Doctors Without Borders' Leishmaniasis Information Page CDC Leishmaniasis Page Portal: Medicine ( ... The visceral form of leishmaniasis has an estimated incidence of 500,000 new cases. In 2014, more than 90% of new cases ... Visceral leishmaniasis or kala-azar ('black fever') is the most serious form, and is generally fatal if untreated. Other ...
... which still feed into the social stigmatization of leishmaniasis today. In India, both cutaneous and visceral leishmaniasis are ... "Canine Visceral Leishmaniasis, United States and Canada, 2000-2003". Emerging Infectious Diseases. 12 (3): 440-446. doi:10.3201 ... has been associated with both cutaneous and visceral leishmaniasis in Venezuela. Genus Endotrypanum Endotrypanum colombiensis ... "Genotypically distinct Leishmania colombiensis isolates from Venezuela cause both cutaneous and visceral leishmaniasis in ...
Engwerda, Christian R.; Matlashewski, G (July 2015). "Development of Leishmania vaccines in the era of visceral leishmaniasis ... Garg, Ravendra; Dube, Anuradha (March 2006). "Animal models for vaccine studies for visceral leishmaniasis" (PDF). Indian ... A Leishmaniasis vaccine is a vaccine which would prevent leishmaniasis. As of 2017, no vaccine for humans was available. ... Currently some effective leishmaniasis vaccines for dogs exist. The parasite which causes leishmaniasis is Leishmania, which is ...
August 2009). "Highly Effective Oral Amphotericin B Formulation against Murine Visceral Leishmaniasis". The Journal of ...
2006). "Canine visceral leishmaniasis, United States and Canada, 2000-2003". Emerging Infect. Dis. 12 (3): 440-6. doi:10.3201/ ... Wikimedia Commons has media related to Canine leishmaniasis. The Canine Leishmaniasis Site by Vetstream Video of Leishmaniasis ... Suspected causes of canine visceral leishmaniasis are geographic variants of the Leishmania donovani complex, including L. ... Canine leishmaniasis (LEESH-ma-NIGH-ah-sis) is a zoonotic disease (see human leishmaniasis) caused by Leishmania parasites ...
Treatment of cutaneous leishmaniasis usually lasts for 20 days and visceral and mucosal leishmaniasis for 28 days. The dose of ... This includes leishmaniasis of the cutaneous, visceral, and mucosal types. Some combination of miltefosine, paramycin and ... Organization, World Health (March 2010). Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the ... It can also be given intralesionally when treating cutaneous leishmaniasis (i.e., injected directly into the area of infected ...
It is an option for both visceral leishmaniasis and cutaneous leishmaniasis. Pentamidine can be given by injection into a vein ... Pentamidine was first used to treat African trypanosomiasis in 1937 and leishmaniasis in 1940 before it was registered as ... Pentamidine is an antimicrobial medication used to treat African trypanosomiasis, leishmaniasis, Balamuthia infections, ... 200mm³ Treatment of leishmaniasis Treatment of African trypanosomiasis caused by Trypanosoma brucei gambiense Balamuthia ...
"The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis". Sci. Transl. Med. 4 (119): 119re1 ... trypanothione metabolism resulted in the discovery that fexinidazole is a potential oral treatment for visceral leishmaniasis. ... Chagas disease and leishmaniasis. He was one of the 250 scientists involved in the genome sequencing of these parasites. In ...
Visceral leishmaniasis and immunocompromise as a risk factor for the development of visceral leishmaniasis: a changing pattern ... Leishmaniasis, Visceral. CDC Yellow Book 2024. Travel-Associated Infections & Diseases Author(s): Rebecca Chancey, Sharon Roy, ... Visceral leishmaniasis (VL) is caused by obligate intracellular protozoan parasites, primarily Leishmania infantum (considered ... Visceral leishmaniasis-associated hemophagocytic lymphohistiocytosis in a traveler returning from a pilgrimage to the Camino de ...
... post kala-azar dermal leishmaniasis. Brahmacharis cure for visceral leishmaniasis was the urea salt of para-amino-phenyl ... Visceral leishmaniasis (VL), also known as kala-azar (Hindi: kālā āzār, "black sickness") or "black fever", is the most severe ... When people develop visceral leishmaniasis, the most typical symptoms are fever and the enlargement of the spleen, with ... 2007). "Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?" (PDF). Nature Reviews Microbiology. 5 ...
Hair breaks. It singes. It falls out. It might not be the strongest feature of living human bodies, but hair is one of the best-preserved tissues of dead ones, providing a record of diet, age, metabolism, and, sometimes, even the cause of death. Ferdinand II* With intense beams of x-rays at Brookhavens National Synchrotron Light Source (NSLS), a team of researchers is using hair samples collected from the decomposed bodies of two 15th century Italian royalty to determine how they really died. The subjects: Ferdinand II (1467-1496)* and Isabella (1470-1524) of Aragon, a medieval kingdom ...
Current infectious disease modeller of Visceral Leishmaniasis in the Indian subcontinent using spatial modelling techniques to ... Visceral leishmaniasis spatiotemporal modelling. I joined the MathSys CDT MSc/PhD programme in September 2015 and in September ... targeting of interventions against visceral leishmaniasis and post-kala-azar dermalLink opens in a new window leishmaniasisLink ... this has led to the collaborative Impact of intensified control strategies on incidence of visceral leishmaniasis in a highly ...
The parasite, however, does not respond to treatment with standard leishmaniasis drugs. ... A new study suggests that transmission of a protozoan parasite from insects may also cause leishmaniasis-like symptoms in ... Emerging parasitic disease mimics the symptoms of visceral leishmaniasis in people. Date:. October 1, 2019. Source:. NIH/ ... The most common forms of leishmaniasis are are cutaneous, which causes skin sores, and visceral, which affects several internal ...
Summary: Combination therapy for the treatment of visceral leishmaniasis has increasingly been advocated as a way to increase ... of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis. ...
Half a million new cases of visceral leishmaniasis occur each year, and 10% of these are fatal. New tools are urgently needed ... 2000) Visceral leishmaniasis control: A public health perspective. Trans R Soc Trop Med Hyg 94: 465-471. * View Article ... Visceral leishmaniasis (VL), commonly known as kala-azar, from the Hindu vernacular, is a human systemic disease caused by ... 9. El-Masum MA, Evans DA, Minter DM, El-Harith A (1995) Visceral leishmaniasis in Bangladesh: The value of DAT as a diagnostic ...
Status of endemicity of visceral leishmaniasis. Published. 2022. Europe. Albania. Endemic. Status of endemicity of visceral ... Status of endemicity of visceral leishmaniasis. Published. 2022. Europe. Armenia. Endemic. Status of endemicity of visceral ... Status of endemicity of visceral leishmaniasis. Published. 2022. Americas. Brazil. Endemic. Status of endemicity of visceral ... Status of endemicity of visceral leishmaniasis. Published. 2022. Africa. Cameroon. Endemic. Status of endemicity of visceral ...
Objective To analyze the dynamics of the spatial and temporal distribution of visceral leishmaniasis in Brazil from 2007 to ... The variables analyzed were the incidence rate of visceral leishmaniasis and the visceral leishmaniasis composite indicator ( ... The incidence of visceral leishmaniasis varied over the trienniums. The border region between the states of Tocantins, Maranhão ... During the study period, there were 48 705 cases of visceral leishmaniasis, with an incidence rate of 25.53 cases per 100 000 ...
The parasite behind visceral leishmaniasis causes a chronic inflammation that enlarges the spleen and creates a hypoxic ... New information on a major player in chronic visceral leishmaniasis. October 3, 2017 , Gisèle Bolduc ... in potentiating suppressor activity and limiting the microbiocidal capacity of MDSC-like cells during visceral leishmaniasis," ... have demonstrated the effect of this key regulator on the function of monocytes and macrophages during viceral leishmaniasis, ...
... infected patients with leishmaniasis who presented with overlapping manifestations between cutaneous and visceral leishmaniasis ... Leishmaniasis is an emerging disease in Thailand. Herein, we report on two human immunodeficiency virus (HIV)- ... Visceral leishmaniasis caused by Leishmania infantum in Thailand. Southeast Asian J Trop Med Public Health 39: 988- 990. ... Visceral leishmaniasis caused by Leishmania infantum in Thailand. Southeast Asian J Trop Med Public Health 39: 988- 990. ...
... is an 8-aminoquinoline in development for the oral treatment of visceral leishmaniasis (VL). This was an open-label, dose- ... Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg 95 (Suppl 1):S27-S58. ... Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg 95 (Suppl 1):S27-S58. ... Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg 95 (Suppl 1):S27-S58. ...
... Assis, Tália Santana Machado de et al. , Data do ... Objective To estimate the sensitivities and specificities of different diagnostic tests for visceral leishmaniasis (VL) using ... Latent class analysis of diagnostic tests for visceral leishmaniasis in Brazil. Tropical Medicine and International Health. ...
... in combination with sodium stibogluconate or miltefosine and miltefosine monotherapy for African visceral leishmaniasis: Phase ... liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label ...
Visceral Leishmaniasis: Is the Brain a Neglected Organ During Canine Infection? World Small Animal Veterinary Association World ... Visceral leishmaniasis is a neglected anthropozoonosis caused by parasitic protozoans from the genus Leishmania, which has the ... this zoonotic protozoan and that the brain should be included in the list of the affected organs during visceral leishmaniasis. ...
Age structure of owned dogs under compulsory culling in a visceral leishmaniasis endemic area. A estrutura etária de cães com ... Dog culling and replacement in an area endemic for visceral leishmaniasis in Brazil. Vet Parasitol 2008; 153:19-23.. This is ... Dog culling and replacement in an area endemic for visceral leishmaniasis in Brazil. Vet Parasitol 2008; 153:19-23. and Andrade ... Dog culling and replacement in an area endemic for visceral leishmaniasis in Brazil. Vet Parasitol 2008; 153:19-23.. ...
Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Kuhlencord, A., Maniera, T., Eibl, H., & Unger, C. ( ... 1992). Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrobial Agents and Chemotherapy, 36(8 ... oral treatment of visceral leishmaniasis in mice. ...
Leishmaniasis is a disease transmitted by the bite of an infected sand fly. See pictures and learn about treatment, symptoms, ... In Visceral Leishmaniasis. In visceral leishmaniasis (VL), the parasite spreads from the skin via the blood and lymph fluids to ... Cutaneous Leishmaniasis. Cutaneous leishmaniasis (CL) is the most common form of leishmaniasis and, as the name implies, the ... leishmaniasis in the last five years. About 300,000 cases of visceral (organ) leishmaniasis occur yearly, with over 20,000 ...
Synthetic sex pheromone in a long-lasting lure attracts the visceral leishmaniasis vector, lutzomyia longipalpis, for up to 12 ... Synthetic sex pheromone in a long-lasting lure attracts the visceral leishmaniasis vector, lutzomyia longipalpis, for up to 12 ... Current control methodologies have not prevented the spread of visceral leishmaniasis (VL) across Brazil. Here, we describe the ... Synthetic sex pheromone in a long-lasting lure attracts the visceral leishmaniasis vector, lutzomyia longipalpis, for up to 12 ...
Abbreviations: AVL=anthroponotic visceral leishmaniasis; MT-ZVL=mountain-type zoonotic visceral leishmaniasis; DT-ZVL=desert- ... Abbreviations: AVL=anthroponotic visceral leishmaniasis; MT-ZVL=mountain-type zoonotic visceral leishmaniasis; DT-ZVL=desert- ... mountain-type zoonotic visceral leishmaniasis (MT-ZVL), and desert-type zoonotic visceral leishmaniasis (DT-ZVL). Their ... anthroponotic visceral leishmaniasis; MT-ZVL=mountain-type zoonotic visceral leishmaniasis; DT-ZVL=desert-type zoonotic ...
American Roentgen Ray Society Images of Visceral leishmaniasis secondary prevention All Images. X-rays. Echo & Ultrasound. CT ... Retrieved from "https://www.wikidoc.org/index.php?title=Visceral_leishmaniasis_secondary_prevention&oldid=1360607" ...
PracticeDiagnosing visceral leishmaniasis. Practice What are the chances of having a second epileptic seizure? ...
The clinical spectrum of leishmaniasis ranges from a self-resolving, localized cutaneous ulcer to widely disseminated ... Leishmaniasis is a disease caused by an intracellular protozoa parasite transmitted by the bite of a female sandfly ( ... Distribution of visceral leishmaniasis. Old World spread of visceral leishmaniasis is via the following:. * L donovani - China ... Visceral and viscerotropic leishmaniasis include the following features:. * Visceral leishmaniasis (kala-azar): Potentially ...
The clinical spectrum of leishmaniasis ranges from a self-resolving, localized cutaneous ulcer to widely disseminated ... Leishmaniasis is a disease caused by an intracellular protozoa parasite transmitted by the bite of a female sandfly ( ... Visceral leishmaniasis. Visceral and viscerotropic disease may manifest with the following physical findings:. * Visceral ... Visceral leishmaniasis. Visceral disease, the most devastating and fatal form of leishmaniasis, is classically known as kala- ...
Visceral Leishmaniasis Data Platform. The VL Data Platform currently holds over 14000 individual patient data from almost 50 ...
Leishmania esophagitis in an AIDS patient: an unusual form of visceral leishmaniasis.. J L Villanueva, J Torre-Cisneros, R ... Although gastrointestinal involvement of leishmaniasis has been previously reported, we believed that we describe the first ...
This is a second year medical school deck about Visceral Leishmaniasis... ...
  • Visceral leishmaniasis (VL) is caused by obligate intracellular protozoan parasites, primarily Leishmania infantum (considered synonymous with L. chagasi ) and L. donovani . (cdc.gov)
  • Visceral leishmaniasis (VL), commonly known as kala-azar, from the Hindu vernacular, is a human systemic disease caused by parasitic protozoan species of the genus Leishmania . (plos.org)
  • Visceral leishmaniasis is a neglected anthropozoonosis caused by parasitic protozoans from the genus Leishmania , which has the dog as the main urban reservoir in South America and in the Mediterranean basin. (vin.com)
  • Leishmaniasis is a disease caused by an intracellular protozoan parasite (genus Leishmania ) transmitted by the bite of a female phlebotomine sandfly. (medscape.com)
  • After recovery or successful treatment, cutaneous leishmaniasis induces immunity to reinfection by the species of Leishmania that caused the disease. (medscape.com)
  • Leishmania esophagitis in an AIDS patient: an unusual form of visceral leishmaniasis. (qxmd.com)
  • Although gastrointestinal involvement of leishmaniasis has been previously reported, we believed that we describe the first case of leishmania esophagitis. (qxmd.com)
  • Impavido (miltefosine) is an antileishmanial agent used to treat visceral leishmaniasis caused by Leishmania donovani , cutaneous leishmaniasis caused by Leishmania braziliensis , Leishmania guyanensis , and Leishmania panamensis , and mucosal leishmaniasis caused by Leishmania braziliensis . (rxlist.com)
  • Visceral leishmaniasis caused by Leishmania donovani [see Clinical Trials ]. (rxlist.com)
  • Cutaneous leishmaniasis caused by Leishmania braziliensis , Leishmania guyanensis , and Leishmania panamensis [see Clinical Trials ]. (rxlist.com)
  • Leishmaniasis is a parasitic disease caused by protozoans of the genus Leishmania . (cwu.edu)
  • Leishmaniasis is a vector-borne disease caused by an obligate intracellular protozoa of genus Leishmania and is transmitted by the bite of a female phlebotomine sand fly ( Figure 1 ). (intechopen.com)
  • Leishmaniasis is caused by a tiny parasite called leishmania protozoa. (medlineplus.gov)
  • Leishmania species: visceral (kala-azar), cutaneous, and mucosal leishmaniasis. (medlineplus.gov)
  • Leishmaniasis, as a vector-borne disease, is transmitted by sandfly and caused by Leishmania protozoa. (ac.ir)
  • The paper published in RSC Medicinal Chemistry tells another chapter in the story of the development of preclinical candidate DDD853651/GSK3186899 for the treatment of visceral leishmaniasis (VL), a disease caused by Leishmania parasites. (galchimia.com)
  • BACKGROUND:As Bangladesh, India and Nepal progress towards visceral leishmaniasis (VL) elimination, it is important to understand the role of asymptomatic Leishmania infection (ALI), VL treatment relapse and post kala-azar dermal leishmaniasis (PKDL) in transmission. (ox.ac.uk)
  • Leishmaniasis is caused by 20 or more species of the protozoa Leishmania . (msdmanuals.com)
  • Medications used to treat the infection depend on the clinical form of leishmaniasis, the status of the person's immune system, which species of Leishmania is causing the infection, and where the infection was acquired. (msdmanuals.com)
  • I assisted with the data cleaning towards Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal Link opens in a new window leishmaniasis Link opens in a new window ( PNAS, September 2020 ). (warwick.ac.uk)
  • According to the World Health Organization, each year between 50,000 and 90,000 people become sick with visceral leishmaniasis (kala-azar), a form of the disease that attacks the internal organs and is fatal in more than 95 percent of cases left untreated. (sciencedaily.com)
  • Another type is visceral leishmaniasis (also called kala-azar or dum-dum fever ). (medicinenet.com)
  • Post-kala-azar dermal leishmaniasis follows the treatment of visceral leishmaniasis and has predominantly been described in Africa (about 2% of cases) and India (about 10% of cases). (medscape.com)
  • Visceral leishmaniasis (kala-azar) affects the internal organs, particularly the bone marrow, lymph nodes, liver, and spleen. (msdmanuals.com)
  • The disease has different clinical forms, ranging from a skin ulcer (cutaneous leishmaniasis, CL), which can heal spontaneously, to the most severe form of visceral leishmaniasis, which can lead to the patient's death when untreated [ 4 ]. (biomedcentral.com)
  • The most common forms of leishmaniasis are are cutaneous, which causes skin sores, and visceral, which affects several internal organs (usually spleen, liver, and bone marrow). (sciencedaily.com)
  • People may have mild or no symptoms or have skin sores (cutaneous leishmaniasis), or sores in the nose, mouth, or throat that can lead to severe disfigurement (mucosal leishmaniasis), or have fever, weight loss, fatigue, and enlargement of the spleen and liver (visceral leishmaniasis). (msdmanuals.com)
  • Mucosal leishmaniasis affects the mucous membranes of the nose and mouth, causing sores and destroying tissue. (msdmanuals.com)
  • Symptoms of mucosal leishmaniasis can develop while the skin sore is present or months to years after the sore heals. (msdmanuals.com)
  • this has led to the collaborative Impact of intensified control strategies on incidence of visceral leishmaniasis in a highly endemic district of Bihar, India (Epidemics, May 2022) Link opens in a new window . (warwick.ac.uk)
  • Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? (ajtmh.org)
  • This ecological study focused on the spatial pattern of visceral leishmaniasis cases in Brazil from 2007 to 2020 using data from the Information System for Notifiable Diseases (SINAN). (paho.org)
  • The global Moran index was calculated to assess the existence of spatial autocorrelation, and the local Moran index was used to identify areas with higher and lower risk of visceral leishmaniasis in Brazil. (paho.org)
  • We analyzed data of an owned-dog census in order to characterize, for the first time, the structure of a dog population under compulsory culling in a visceral leishmaniasis endemic area (Panorama, São Paulo State, Brazil) that recorded a dog-culling rate of 28% in the year of the study. (scielosp.org)
  • The most visceral disease occurs in East Africa, Brazil, and India. (medicinenet.com)
  • This is mucocutaneous leishmaniasis and only occurs in limited areas of Bolivia, Brazil, and Peru. (medicinenet.com)
  • Current control methodologies have not prevented the spread of visceral leishmaniasis (VL) across Brazil. (gre.ac.uk)
  • Spatio-temporal analysis of the visceral leishmaniasis in the state of Alagoas, Brazil. (bvsalud.org)
  • We evaluated the spatial distribution of cases of visceral leishmaniosis in the state of Alagoas, Brazil . (bvsalud.org)
  • Leishmaniasis occurs in several temperate and tropical countries of Central and South America (New World), the Middle East, East Africa, and East Asia (Old World). (medicinenet.com)
  • Cutaneous leishmaniasis is most common in Central and South America, the Middle East, and North and East Africa. (medicinenet.com)
  • New World' (Western hemisphere) leishmaniasis occurs in tropical parts of Mexico and Central and South America. (medicinenet.com)
  • It is difficult to pinpoint how many cases occur globally, since most may occur in rural, poor areas without established systems of reporting, but the World Health Organization (WHO) reports over 1 million cases of cutaneous (skin) leishmaniasis in the last five years. (medicinenet.com)
  • The variables analyzed were the incidence rate of visceral leishmaniasis and the visceral leishmaniasis composite indicator (VLCI), from which triennial thematic maps were constructed. (paho.org)
  • During the study period, there were 48 705 cases of visceral leishmaniasis, with an incidence rate of 25.53 cases per 100 000 population. (paho.org)
  • The incidence of visceral leishmaniasis varied over the trienniums. (paho.org)
  • Incidence and Disability-Adjusted Life Years (DALYS) Attributable to Leishmaniasis in Iran, 2013. (ac.ir)
  • With temporal evolution, the incidence of cases of visceral leishmaniosis was concentrated in most municipalities in the microregion of Santana do Ipanema-AL. (bvsalud.org)
  • Visceral Leishmaniasis: Is the Brain a Neglected Organ During Canine Infection? (vin.com)
  • Travi BL, Cordeiro-da-Silva A, Dantas-Torres F, Miró G. Canine visceral leishmaniasis: diagnosis and management of the reservoir living among us. (chinacdc.cn)
  • Canine visceral leishmaniasis in Evora district, Portugal : a sero-epidemiological study = Viscerale leishmaniasis bij honden in het Evora district, Portugal : een sero-epidemiologisch onderzoek = Leishmaniose visceral canina no concelho de Evora, Portugal : um estudo sero-epidemiológico / door Saul José Semião-Santos. (who.int)
  • Neurological disease in human and canine leishmaniasis-clinical features and immunopathogenesis. (ac.ir)
  • Acute phase proteins as predictors of disease activity in tropical infections : visceral leishmaniasis and tuberculosis / Kevin Monique Ajilong Wasunna. (who.int)
  • Less commonly, people who have had cutaneous leishmaniasis may get new sores in the mucous membranes of the mouth, nose, and larynx even years after the cutaneous leishmaniasis has resolved. (medicinenet.com)
  • Cutaneous leishmaniasis affects the skin and mucous membranes. (medlineplus.gov)
  • Leishmaniasis includes several disorders that affect the skin, the mucous membranes of the nose, mouth, or throat or internal organs including the liver, spleen, and bone marrow. (msdmanuals.com)
  • The authors are all members of the Leishmaniasis East Africa Platform and are currently engaged in the clinical development of paromomycin for treatment of visceral leishmaniasis. (plos.org)
  • Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). (ox.ac.uk)
  • Old World' (Eastern hemisphere) leishmaniasis occurs in tropical parts of Asia, the Middle East, East and North Africa, and southern Europe. (medicinenet.com)
  • ABSTRACT Leishmaniasis causes significant morbidity and mortality in areas where it is endemic. (who.int)
  • abstract = "In 1994-1995, a child and five dogs from villages located between Jerusalem and Tel-Aviv, Israel were diagnosed with visceral leishmaniasis (VL). (huji.ac.il)
  • abstract = "In this paper, we discuss some of the dynamical characteristics of a visceral leishmaniasis (VL) model with time delay. (elsevierpure.com)
  • Visceral leishmaniasis (VL) is an important vector-borne disease in rural areas of western China. (chinacdc.cn)
  • See information on specimen collection and diagnosis of leishmaniasis [PDF]. (cdc.gov)
  • A new study suggests that transmission of a protozoan parasite from insects may also cause leishmaniasis-like symptoms in people. (sciencedaily.com)
  • The parasite, however, does not respond to treatment with standard leishmaniasis drugs. (sciencedaily.com)
  • The parasite behind visceral leishmaniasis causes a chronic inflammation that enlarges the spleen and creates a hypoxic microenvironment. (inrs.ca)
  • A parasite that spreads to humans through the bite of infected Phlebotomus sand flies causes leishmaniasis. (medicinenet.com)
  • Treatment consists of medications that are specific to the type of leishmaniasis, the species of the parasite, and the country in which the patient acquired the disease. (medicinenet.com)
  • Leishmaniasis is a vector-borne tropical/subtropical disease caused by an intracellular parasite transmitted to humans by sand fly bite. (intechopen.com)
  • Health researchers expect human leishmaniasis to follow the spread of Phlebotomus flies into regions of increasing warmth and humidity. (medicinenet.com)
  • Llanos-Cuentas A, Valencia BM, Petersen CA. Neurological manifestations of human leishmaniasis. (ac.ir)
  • Mucocutaneous leishmaniasis consists of the relentless destruction of the oropharynx and nose, resulting in extensive midfacial destruction. (medscape.com)
  • New World disease may progress to mucocutaneous leishmaniasis. (medscape.com)
  • Mucocutaneous leishmaniasis (MCL) can lead to severe facial disfigurement if left untreated but is not particularly deadly. (cwu.edu)
  • McNolty, Alan K., "Antibody Dependent Enhancement of Visceral Leishmaniasis" (2018). (cwu.edu)
  • The 63-year old patient initially sought treatment for the symptoms of visceral leishmaniasis, including weight loss, fever, anemia, and an enlarged liver and spleen. (sciencedaily.com)
  • However, after eight months of standard leishmaniasis treatment, the patient's symptoms had not improved. (sciencedaily.com)
  • Contact your provider if you have symptoms of leishmaniasis after visiting an area where the disease is known to occur. (medlineplus.gov)
  • This originates the clinical manifestations of leishmaniasis. (plos.org)
  • The broad spectrum of clinical manifestations of cutaneous leishmaniasis often is compared with that of leprosy. (medscape.com)
  • Leishmaniasis is transmitted by the bite of female phlebotomine sandflies. (plos.org)
  • You will be asked if you recall being bitten by sandflies or if you've been in an area where leishmaniasis is common. (medlineplus.gov)
  • Altogether, these data are further evidence that there is in the brain an inflammatory response during the peripheral infection by this zoonotic protozoan and that the brain should be included in the list of the affected organs during visceral leishmaniasis. (vin.com)
  • HIV -visceral leishmaniasis ( HIV -VL) co-infection has emerged in southern Europe and elsewhere. (medicinenet.com)
  • Leishmaniasis is a 'vector-borne' infection, meaning that an insect from another host or 'reservoir' (disease carrier) transmits it. (medicinenet.com)
  • Active cutaneous leishmaniasis lesion with likely secondary infection in a soldier. (medscape.com)
  • This systematic review by Prabin Dahal and colleagues found that reports on the occurrence of Visceral Leishmaniasis (VL) in pregnant women are rare in published literature, are not systematically captured, and cases are rarely followed-up to detect the consequences of infection and treatment on the pregnant woman and foetus. (ox.ac.uk)
  • Both New World and Old World species cause localized cutaneous leishmaniasis. (medscape.com)
  • WHO considers Leishmaniasis as one of the "Neglected Tropical Diseases" that continues to be prevalent despite international, national, and local efforts towards its control and elimination over the last decade. (intechopen.com)
  • All these challenges related to environment, disease, and vector pose major implications on WHO's leishmaniasis control and elimination plan. (intechopen.com)
  • Efficacy and safety of liposomal amphotericin B (Am-Bisome) for visceral leishmaniasis in endemic developing countries. (ajtmh.org)
  • Despite the limitations and paucity of data, the most comprehensive review of visceral leishmaniasis to date in pregnant women and vertical transmission of leishmaniasis has confirmed that liposomal amphotericin B is the safest treatment option and it is critical to ensure access to this. (ox.ac.uk)
  • Miltefosine: great expectations against visceral leishmaniasis. (ajtmh.org)
  • Miltefosine: an oral drug for visceral leishmaniasis. (ajtmh.org)
  • Professor Stäger and her team have demonstrated the effect of this key regulator on the function of monocytes and macrophages during viceral leishmaniasis, the most severe form of a tropical disease that affects millions of people around the world. (inrs.ca)
  • Background: Febrile illnesses like malaria, typhoid, and tuberculosis are the commonestproblems in our area, but visceral leishmaniasis (VL) is also one of the diseases presenting withfever in this part of the country. (edu.pk)
  • The clinical spectrum of leishmaniasis ranges from a self-resolving cutaneous ulcer to a mutilating mucocutaneous disease and even to a lethal systemic illness. (medscape.com)
  • Mohebali M. Visceral leishmaniasis in Iran: Review of the Epidemiological and Clinical Features. (ac.ir)
  • DT-ZVL=desert-type zoonotic visceral leishmaniasis. (chinacdc.cn)
  • The visceral form of the disease is caused by parasitic infiltration of internal organs, particularly the spleen, liver, and bone marrow. (cwu.edu)
  • Current epidemiological profile and features of visceral leishmaniasis in people's republic of China. (chinacdc.cn)
  • Visceral leishmaniasis in Somalia : immunodiagnostic and epidemiological aspects / by Shukri Ali Shiddo. (who.int)
  • Os autores analisaram os dados de um censo de cães com donos para caracterizar, pela primeira vez, a estrutura etária de uma população canina sujeita à eliminação compulsória numa área endêmica de leishmaniose visceral (Panorama, Estado de São Paulo, Brasil) que registrou uma taxa de eliminação canina de 28% no ano do estudo. (scielosp.org)
  • Se analizaron datos de un censo de población canina domiciliada, con el objetivo de caracterizar, por primera vez, la estructura de una población de perros domiciliados en un área donde la eutanasia de perros positivos en leishmaniasis visceral es obligatoria (Panorama, São Paulo, Brasil), y que registró un 28% de casos de eutanasia en el año en que el censo fue realizado. (scielosp.org)
  • Plastic surgery may be needed to correct the disfigurement caused by sores on the face (cutaneous leishmaniasis). (medlineplus.gov)
  • Cutaneous leishmaniasis may lead to disfigurement. (medlineplus.gov)
  • Combination therapy for the treatment of visceral leishmaniasis has increasingly been advocated as a way to increase treatment efficacy and tolerance, reduce treatment duration and cost, and limit the emergence of drug resistance. (dndi.org)
  • Leishmaniasis is a parasitic disease found in parts of the tropics, subtropics, and southern Europe. (sciencedaily.com)
  • Brain involvement rarely occurs in visceral leishmaniasis. (ac.ir)
  • Leishmaniasis occurs in scattered areas throughout the world. (msdmanuals.com)
  • Leishmaniasis recidivans may occur years after a localized cutaneous lesion has healed, commonly presenting on the face (see the following image). (medscape.com)
  • In other regions, such as the United States and Europe, travelers from affected areas may have leishmaniasis. (medicinenet.com)
  • While cutaneous leishmaniasis (CL) is often self-healing, visceral leishmaniasis (VL) is fatal if left untreated. (cwu.edu)
  • Leishmaniasis is an infectious disease spread by the bite of the female sandfly. (medlineplus.gov)
  • Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. (ajtmh.org)
  • VL causes an estimated 50,000 deaths annually, a rate surpassed among parasitic diseases only by malaria, and 2,357,000 disability-adjusted life years lost, placing leishmaniasis ninth in a global analysis of infectious diseases [ 9 ]. (biomedcentral.com)
  • This chapter reviews the global perspective of Leishmaniasis with increasing recognition of emerging "Atypical forms" and new surge of disease across the world mainly due to increasing conflicts in endemic areas leading to forced migration among other causes. (intechopen.com)
  • Visceral leishmaniosis is a neglected tropical disease . (bvsalud.org)
  • Leishmaniasis produces a spectrum of disease. (msdmanuals.com)
  • Visceral Leishmaniasis (VL) and Cutaneous Leishmaniasis (CL) in Iran as well as Chronic Vascular Disease (CVD) were used as case study diseases. (lu.se)
  • Une enquête de séroprévalence a été réalisée dans 2 villages d'endémie à Dera (République arabe syrienne) où 80 enfants sur 345 (23,2 %) ont été testés positifs à la leishmaniose viscérale en utilisant le test rapide sur bandelette réactive rK39. (who.int)
  • Os parâmetros estimados podem ser aplicados também a modelos para maximizar o impacto e minimizar os insumos financeiros de medidas de controle da leishmaniose visceral. (scielosp.org)